Draganfly (DPRO) 6-K 10 May 22 Current report (foreign) Financial data

Cover

Cover	3 Months Ended
	Mar. 31, 2022
Cover [Abstract]
Document Type	6-K
Amendment Flag	false
Document Period End Date	Mar. 31, 2022
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--12-31
Entity File Number	001-40688
Entity Registrant Name	DRAGANFLY INC.
Entity Central Index Key	0001786286
Entity Address, Address Line One	2108 St. George Avenue
Entity Address, City or Town	Saskatoon
Entity Address, State or Province	SK
Entity Address, Country	CA
Entity Address, Postal Zip Code	S7M OK7

Condensed Consolidated Interim

Condensed Consolidated Interim Statements of Financial Position - CAD ($)	Mar. 31, 2022	Dec. 31, 2021
Current Assets
Cash and cash equivalents	$ 19,576,902	$ 23,075,713
Receivables	1,951,445	1,407,127
Inventory	3,365,173	3,390,822
Notes receivable	967,766	190,170
Prepaids	3,352,552	5,494,877
Total current assets	29,213,838	33,558,709
Non-current Assets
Goodwill	5,886,233	5,940,409
Equipment	293,179	297,043
Intangible assets	544,424	593,901
Investments	257,817	291,066
Notes receivable	961,721	964,006
Right of use asset	437,266	468,106
TOTAL ASSETS	37,594,478	42,113,240
Current Liabilities
Trade payables and accrued liabilities	668,988	799,139
Customer deposits	209,535	172,134
Deferred income	(4,330)	73,286
Loans payable	6,745	6,745
Derivative liability	6,790,862	5,560,002
Lease liability	115,269	110,481
Total current liabilities	7,787,069	6,721,787
Non-current Liabilities
Loans payable	86,161	86,572
Lease liability	348,198	378,642
TOTAL LIABILITIES	8,221,428	7,187,001
SHAREHOLDERS’ EQUITY
Share capital	81,159,345	81,038,365
Reserves – share-based payments	7,024,442	6,406,117
Accumulated deficit	(58,526,517)	(52,322,182)
Accumulated other comprehensive (loss)	(284,220)	(196,061)
TOTAL SHAREHOLDERS’ EQUITY	29,373,050	34,926,239
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$ 37,594,478	$ 42,113,240

Condensed Consolidated Interi_2

Condensed Consolidated Interim Statements of Comprehensive Loss (Unaudited) - CAD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
REVENUE
Revenue from sales of goods	$ 1,637,716	$ 1,129,307
Revenue from provision of services	406,846	410,429
TOTAL REVENUE	2,044,562	1,539,736
COST OF SALES	(1,228,412)	(1,024,729)
GROSS PROFIT	816,150	515,007
OPERATING EXPENSES
Amortization	44,540	13,694
Depreciation	47,147	35,302
Director fees	107,446	86,691
Insurance	1,458,765	13,615
Office and miscellaneous	1,607,837	2,325,786
Professional fees	873,640	868,479
Research and development	314,440	15,048
Share-based payments	643,325	1,049,866
Travel	76,472	28,758
Wages and salaries	1,000,207	402,361
Total operating expenses	(6,173,819)	(4,839,600)
OTHER INCOME (EXPENSE)
Change in fair value of derivative liability	(1,230,860)	(41,019,172)
Finance and other costs	14,148	(6,405)
Foreign exchange gain (loss)	(386,940)	145,095
loss on disposal of assets	(10,755)
Government income	1,275	20,706
Gain on recovery of notes receivable	771,260
Other loss	(4,794)	(16,708)
NET LOSS	(6,204,335)	(45,201,077)
Items that may be reclassified to profit or loss
Foreign exchange translation	(54,910)	9,287
Items that will not be reclassified to profit or loss
Change in fair value of equity investments at FVOCI	(33,249)	277,143
COMPREHENSIVE LOSS	$ (6,292,494)	$ (44,914,647)
Net loss per share
Basic & diluted	$ (0.19)	$ (2.15)
Weighted average number of common shares outstanding - basic & diluted	33,185,860	20,980,046

Condensed Consolidated Interi_3

Condensed Consolidated Interim Statements of Changes in Shareholders' Equity (Unaudited) - CAD ($)	Issued capital [member]	Reserve of share-based payments [member]	Retained earnings [member]	Reserve of gains and losses from investments in equity instruments [member]	Reserve of exchange differences on translation [member]	Total
Beginning balance, value at Dec. 31, 2020	$ 36,943,304	$ 3,024,007	$ (36,119,210)		$ 104	$ 3,848,205
Beginning balance, shares at Dec. 31, 2020	17,218,695
IfrsStatementLineItems [Line Items]
Shares issued for acquisition	$ 2,303,999	1,241,250				3,545,249
Shares issued for acquisition, shares	1,200,000
Shares issued for financing	$ 18,717,438					18,717,438
Shares issued for financing, shares	6,488,669
Share issue costs	$ (273,169)					(273,169)
Shares issued for exercise of RSUs	$ 300,000	(300,000)
Shares issued for exercise of RSUs, shares	125,000
Shares issued for exercise of warrants	$ 3,507,562					3,507,562
Shares issued for exercise of warrants, shares	1,403,025
Shares issued for exercise of stock options	$ 1,846,776	(891,403)				955,373
Shares issued for exercise of stock options, shares	378,499
Shares issued in lieu of cash	$ 198,000					198,000
Shares issued in lieu of cash, shares	15,000
Share-based payments		1,049,866				1,049,866
Net loss			(45,201,077)			(45,201,077)
Change in fair value of equity investments at FVOCI				277,143		277,143
Translation of foreign operations					9,287	9,287
Ending balance, value at Mar. 31, 2021	$ 63,543,910	4,123,720	(81,320,287)	277,143	9,287	(13,366,123)
Ending balance, shares at Mar. 31, 2021	26,828,887
IfrsStatementLineItems [Line Items]
Shares issued for financing	$ 17,374,749					17,374,749
Shares issued for financing, shares	5,095,988
Share issue costs	$ (4,405,652)	864,000				(3,541,592)
Shares issued for exercise of RSUs	$ 1,452,052	(1,452,052)
Shares issued for exercise of RSUs, shares	323,660
Shares issued for exercise of warrants	$ 1,422,228					1,422,228
Shares issued for exercise of warrants, shares	536,509
Shares issued for exercise of stock options	$ 91,090	(32,340)				58,750
Shares issued for exercise of stock options, shares	27,000
Shares issued in lieu of cash	$ 1,559,988					1,559,988
Shares issued in lieu of cash, shares	356,901
Share-based payments		2,902,729				2,902,729
Net loss			28,998,105			28,998,105
Change in fair value of equity investments at FVOCI				(609,783)		(609,783)
Translation of foreign operations					127,188	127,188
Ending balance, value at Dec. 31, 2021	$ 81,038,365	6,406,117	(52,322,182)	(332,640)	136,579	34,926,239
Ending balance, shares at Dec. 31, 2021	33,168,946
IfrsStatementLineItems [Line Items]
Share issue costs	$ (5,122)					(5,122)
Shares issued for exercise of warrants	$ 74,227					74,227
Shares issued for exercise of warrants, shares	16,538
Shares issued for exercise of stock options	$ 51,875	(25,000)				26,875
Shares issued for exercise of stock options, shares	12,500
Share-based payments		643,325				643,325
Net loss			(6,204,335)			(6,204,335)
Change in fair value of equity investments at FVOCI				(33,249)		(33,249)
Translation of foreign operations					(54,910)	(54,910)
Ending balance, value at Mar. 31, 2022	$ 81,159,345	$ 7,024,442	$ (58,526,517)	$ (365,889)	$ 81,669	$ 29,373,050
Ending balance, shares at Mar. 31, 2022	33,197,984

Condensed Consolidated Interi_4

Condensed Consolidated Interim Statements of Cash Flows (Unaudited) - CAD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
OPERATING ACTIVITIES
Net loss	$ (6,204,335)	$ (45,201,077)
Adjustments for:
Amortization	44,540	13,694
Depreciation	47,147	35,302
Change in fair value of derivative liability	1,230,860	41,019,172
Impairment of notes receivable	(771,260)
Finance and other costs	(140)	6,405
Income from government assistance	(1,275)	(20,706)
Share-based payments	643,325	1,049,866
Adjustment for profit loss	(5,011,138)	(3,097,344)
Net changes in non-cash working capital items:
Receivables	(544,318)	(136,170)
Inventory	25,649	(143,786)
Prepaids	2,142,325	33,881
Right of use asset		(14,365)
Trade payables and accrued liabilities	(47,704)	(188,645)
Customer deposits	37,401	(95,646)
Deferred income	(91,385)	(3,870)
Funds used in operating activities	(3,489,170)	(3,645,945)
INVESTING ACTIVITIES
Cash paid for acquisition, net of cash received		(250,000)
Purchase of equipment	(23,197)	(99,655)
Disposal of equipment	10,755
Purchase of investments		(500,000)
Funds used in investing activities	(12,442)	(849,655)
FINANCING ACTIVITIES
Proceeds from issuance of common shares for financing		18,717,438
Share issue costs	(5,122)	(273,169)
Proceeds from issuance of common shares for warrants exercised	74,227	3,507,562
Proceeds from issuance of common shares for stock options exercised	26,875	955,373
Proceeds from issuance of common shares in lieu of cash		198,000
Proceeds from issuance of loans		503,870
Loans repayments	(1,686)	(24,513)
Repayment of lease liability	(36,583)	(12,741)
Funds provided by financing activities	57,711	23,571,820
Effects of exchange rate changes on cash	(54,910)	9,287
Change in cash	(3,443,901)	19,076,220
Cash, beginning of year	23,075,713	1,982,416
Cash, end of year	19,576,902	21,067,923
Cash and cash equivalents consist of the following:
Cash held in banks	19,231,149	20,925,211
Guaranteed investment certificate	345,753	142,712
Cash and cash equivalents	$ 19,576,902	$ 21,067,923

NATURE AND CONTINUANCE OF OPERA

NATURE AND CONTINUANCE OF OPERATIONS	3 Months Ended
	Mar. 31, 2022
Nature And Continuance Of Operations
NATURE AND CONTINUANCE OF OPERATIONS	1. NATURE AND CONTINUANCE OF OPERATIONS Draganfly Inc. (the “Company”) was incorporated on June 1, 2018 under the Business Corporations Act (British Columbia). The Company’s shares trade on the Canadian Securities Exchange (the “CSE”), on the Nasdaq Capital Market (the “Nasdaq”) under the symbol “DPRO” and on the Frankfurt Stock Exchange under the symbol “3U8”. The Company’s head office is located at 2108 St. George Avenue, Saskatoon, SK, S7M 0K7 and its registered office is located at 2800 – 666 Burrard Street, Vancouver, BC, V6C 2Z7. COVID-19 The coronavirus, also known as “COVID-19,” spread across the globe and is ‎impacting worldwide economic activity. Government authorities in many jurisdictions have implemented ‎measures to mitigate the spread of the virus. These measures, which include the ‎implementation of travel bans, self-imposed quarantine periods, and social distancing, have ‎caused disruption to business globally. ‎ ‎ ‎ The Company will continue to monitor the impact of the COVID-19 pandemic, the duration and ‎impact of which is unknown at this time which may include further disruptions to global supply chains and the manufacturing and delivery of parts that the Company relies on for its products. Although it is not possible to reliably estimate the length and ‎severity of these developments and the impact on the financial results and condition of the ‎Company and its operations in future periods, such impacts are not expected to be ‎significant going forward. Aside from the acquisition of Dronelogics and being opportunistic ‎on ‎other partnerships or acquisitions, the Company has expanded its products and services offered ‎to include ‎health and telehealth applications relating to COVID-19, as a way to mitigate the ‎effects of COVID-19. Draganfly Inc. Notes to the Condensed Consolidated Interim Financial Statements For The Three Months Ended March 31, 2022 Expressed in Canadian Dollars (unaudited)

BASIS OF PREPARATION

BASIS OF PREPARATION	3 Months Ended
	Mar. 31, 2022
BASIS OF PREPARATION	2. BASIS OF PREPARATION Statement of Compliance These consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”) and interpretations issued by the International Reporting Interpretation Committee (“IFRIC”). The principal accounting policies applied in the preparation of these interim financial statements, including International Accounting Standards (“IAS”) 34 Interim Financial Reporting, are set out below. These policies have been consistently applied to all years presented, unless otherwise stated. The notes presented in these condensed consolidated interim financial statements include only significant events and transactions occurring since the Company’s last fiscal year end and they do not include all of the information required in the Company’s most recent annual financial statements. Except as noted below, these condensed consolidated interim financial statements follow the same accounting policies and methods of application as the Company’s annual financial statements and should be read in conjunction with the Company’s annual financial statements for the year ended December 31, 2021, which were prepared in accordance with IFRS as issued by IASB. There have been no significant changes in judgement or estimates from those disclosed in the financial statements for the year ended December 31, 2021. These consolidated financial statements were authorized for issue by the Board of Directors on May 10, 2022. The financial statements of the Company have been prepared on a historical cost basis, modified where applicable. In addition, the financial statements have been prepared using the accrual basis of accounting except for cash flow information Basis of consolidation Each subsidiary is fully consolidated from the date of acquisition, being the date on which the Company obtains control, and continue to be consolidated until the date when such control ceases. The consolidated financial statements include the accounts and results of operations of the Company and its wholly owned subsidiaries listed in the following table: SCHEDULE OF RESULTS OF OPERATIONS Name of Subsidiary Place of Incorporation Ownership Interest Draganfly Innovations Inc. Canada 100 % Draganfly Innovations USA, Inc. US 100 % Dronelogics Systems Inc. Canada 100 % All intercompany balances and transactions were eliminated on consolidation.

RESTATEMENT TO PREVIOUS PERIODS

RESTATEMENT TO PREVIOUS PERIODS	3 Months Ended
	Mar. 31, 2022
Restatement To Previous Periods
RESTATEMENT TO PREVIOUS PERIODS	3. RESTATEMENT TO PREVIOUS PERIODS The comparative financial information of the Company as at March 31, 2021 has been adjusted as follows: Vital Intelligence Inc. (“Vital”) acquisition In the prior period financial statements as at March 31, 2021, the Company recorded the contingent consideration with respect to the Vital acquisition (note 4) as equity. Upon management’s review at December 31, 2021, management determined that the contingent consideration did not meet the criteria to recognize it as an asset and thus reclassified it as a contingent liability. This change also resulted in the removal of the contingent shares from the weighted average number of shares calculation. As a result of the change, the following adjustments were made to the comparative financial information: SCHEDULE OF ADJUSTMENTS TO COMPARATIVE FINANCIAL INFORMATION As at March 31, 2021 Amounts before restatement Restatement Amounts restated Condensed consolidated interim statement of loss Weighted average number of shares outstanding – basic & diluted 21,070,046 (90,000 ) 20,980,046 Net loss per share – basic and diluted $ (2.15 ) $ - $ (2.15 ) For the three months ended March 31, 2021 Condensed consolidated interim statement of changes in shareholders’ equity $ $ $ Share capital 75,459,911 (11,916,001 ) 63,543,910 Equity reserve 5,955,327 (1,831,607 ) 4,123,720 Balance at March 31, 2021 381,485 (13,747,308 ) (13,366,123 ) Draganfly Inc. Notes to the Condensed Consolidated Interim Financial Statements For The Three Months Ended March 31, 2022 Expressed in Canadian Dollars (unaudited)

VITAL ACQUISITION

VITAL ACQUISITION	3 Months Ended
	Mar. 31, 2022
Vital Acquisition
VITAL ACQUISITION	4. VITAL ACQUISITION On March 25, 2021, the Company acquired the assets of Vital, a company that had developed a health/telehealth platform that could detect a number of key underlying respiratory symptoms. The Company acquired it to diversify it’s existing product line as well as recognized opportunities that an initial focus on COVID-19 screening set of technologies would most likely lead to other facets within the healthcare field creating revenue growth from a new vertical, for consideration of: (a) a cash payment of $ 500,000 ‎1,200,000 the Company with each unit being comprised of one common share and one warrant (the “Acquisition”). Each warrant will entitle the holder to acquire one common share for a period of 24 ‎months following closing for $ 13.35 300,000 The units were issued on March 22, 2021 250,000 227,984 The units of the Company are to be released from escrow as follows: a) 300,000 units shall be released on the closing date (released); b) 300,000 2,000,000 c) 300,000 4,000,000 d) 300,000 6,000,000 The 900,000 the weighted average probability of achieving the milestones necessary to release the shares held in escrow, 900,000 On acquisition, the fair value of the derivative liability (note 17) was $ 4,797,717 . At March 31, 2022, the liability was revalued based upon new weighted average probabilities of achieving the revenue milestones. As a result, the fair value was adjusted to $ 976,816 , with the difference flowing through the condensed consolidated interim statement of loss. SCHEDULE OF CONTINGENT CONSIDERATION Contingent consideration Fair value of contingent consideration $ 4,797,717 Change in fair value of contingent consideration (4,103,487 ) Contingent consideration at December 31, 2021 694,230 Change in fair value of contingent consideration 282,587 Contingent consideration at March 31, 2022 (note 17) $ 976,816 Draganfly Inc. Notes to the Condensed Consolidated Interim Financial Statements For The Three Months Ended March 31, 2022 Expressed in Canadian Dollars (unaudited) 4. VITAL ACQUISITION (CONT’D) The purchase price allocation (“PPA”) is as follows: SCHEDULE OF PURCHASE PRICE ALLOCATION FOR VITAL INTELLIGENCE Number of units of Draganfly Inc. 578,248 Fair value of units $ 14.43 Fair value of units of Draganfly Inc. $ 8,342,966 Cash portion of purchase price 466,643 Total $ 8,809,609 Identifiable intangible assets Brand $ 23,000 Software 433,000 Identifiable intangible assets 456,000 Goodwill 8,353,609 Total consideration $ 8,809,609 Significant estimates are as follows: ● Number of units issued based upon a weighted average calculation for the Company achieving the revenue targets. ● Brand fair value based on an income approach, specifically relief from royalty methodology, using a reasonable royalty rate of 0.25% 14.4% ● Software fair value based on an income approach, specifically relief from royalty methodology, using a reasonable royalty rate of 5.0% 14.4% Furthermore, the excess of the consideration paid over the fair value of the identifiable assets acquired was recognized as goodwill.

CASH AND CASH EQUIVALENTS

CASH AND CASH EQUIVALENTS	3 Months Ended
	Mar. 31, 2022
CASH AND CASH EQUIVALENTS	5. CASH AND CASH EQUIVALENTS SCHEDULE OF CASH AND CASH EQUIVALENTS March 31, 2022 December 31, 2021 Cash held in banks $ 19,231,149 $ 22,729,212 Guaranteed investment certificates 345,753 346,501 Cash and Cash Equivalents $ 19,576,902 $ 23,075,713 Draganfly Inc. Notes to the Condensed Consolidated Interim Financial Statements For The Three Months Ended March 31, 2022 Expressed in Canadian Dollars (unaudited)

RECEIVABLES

RECEIVABLES	3 Months Ended
	Mar. 31, 2022
Schedule Of Amounts Receivable
RECEIVABLES	6. RECEIVABLES SCHEDULE OF AMOUNTS RECEIVABLE March 31, 2022 December 31, 2021 Trade accounts receivable $ 1,458,502 $ 951,314 Corporate taxes receivable 182,820 182,820 GST receivable 310,123 $ 272,993 Trade and other receivables $ 1,951,445 $ 1,407,127

INVENTORY

INVENTORY	3 Months Ended
	Mar. 31, 2022
INVENTORY	7. INVENTORY SCHEDULE OF INVENTORIES March 31, 2022 December 31, 2021 Finished goods $ 2,997,812 $ 3,017,363 Parts 367,361 373,459 Inventories $ 3,365,173 $ 3,390,822 During the three months ended March 31, 2022, $ 1,161,511 (2021: $ 784,095 ) of inventory was recognized in cost of sales. Cost of assets sold consist of the following: SCHEDULE OF COST OF SALES March 31, 2022 March 31, 2021 Inventory $ 1,161,511 $ 784,095 Consulting and services 64,833 162,393 Other 2,068 78,241 Cost of sales $ 1,228,412 $ 1,024,729

NOTES RECEIVABLE

NOTES RECEIVABLE	3 Months Ended
	Mar. 31, 2022
Notes Receivable
NOTES RECEIVABLE	8. NOTES RECEIVABLE DISCLOSURE OF NOTES RECEIVABLE Start Date Maturity Date Rate Principal Interest Accretion Impairment recovery Total Note 1 (1) 2021-04-21 2022-10-21 0 % $ 178,223 $ - $ 3,488 $ - $ 181,711 Note 2 (1) 2021-09-22 2024-09-22 5 % 943,544 11,555 6,622 - 961,721 Note 3 2021-11-17 2022-04-26 8 % - 14,795 - 771,260 786,055 Total $ 1,121,767 $ 26,350 $ 10,110 $ 771,260 $ 1,929,487 (1) These notes are denominated in US dollars and are converted to Canadian dollars at the reporting date. Current assets Non-Current assets Note 1 $ 181,711 $ - Note 2 - 961,721 Note 3 786,055 - Notes receivable $ 967,766 $ 961,721 Note 1 is non-interest bearing and is secured by intellectual property. This note is measured at fair value through profit or loss. The fair value was determined based on the price the company paid for this loan which was the investee’s most recent financing. Note 2 bears interest at 5% Note 3 was issued pursuant to letter of intent on an acquisition that the Company is no longer pursuing. The loan is interest bearing at 8% and is due April 26, 2022 . At December 31, 2021, management determined that it was unlikely that either the loan will be repaid or the Company will receive some other type of return, therefore, the loan was written down to $ nil . During the three months ended March 31, 2022, the parties agreed on a repayment plan, with $ 450,000 to be paid upon execution of the agreement, and the remaining balance to be paid within 90 days of the signed agreement. Subsequent to March 31, 2022 the $ 450,000 payment was received (note 22). Draganfly Inc. Notes to the Condensed Consolidated Interim Financial Statements For The Three Months Ended March 31, 2022 Expressed in Canadian Dollars (unaudited)

PREPAIDS

PREPAIDS	3 Months Ended
	Mar. 31, 2022
PREPAIDS	9. PREPAIDS SCHEDULE OF PREPAID EXPENSES AND DEPOSITS March 31, 2022 December 31, 2021 Insurance $ 1,464,830 $ 2,938,246 Prepaid director fees 107,778 107,763 Prepaid interest 2,699 6,969 Prepaid marketing services 1,173,062 1,638,179 Prepaid rent 10,255 - Prepaid subscriptions 6,611 35,687 Deposits 587,317 768,033 Prepaid expenses and deposits $ 3,352,552 $ 5,494,877

INVESTMENTS

INVESTMENTS	3 Months Ended
	Mar. 31, 2022
Disclosure of detailed information about investment property [abstract]
INVESTMENTS	10. INVESTMENTS SCHEDULE OF INVESTMENTS Balance at December 31, 2021 $ 291,066 Change in fair value (33,249 ) Balance at December 31, 2021 $ 257,817 Fair value of investments is comprised of: Public company shares $ 128,571 Public company warrants 4,286 Private company shares 124,960 Balance at December 31, 2021 $ 257,817 On March 10, 2021, the Company purchased 1,428,571 units of a publicly listed company for $ 500,000 . Each unit is comprised of one common share and one warrant. The warrants have an exercise price of $0.50 each and convert to one common share, and expire on March 17, 2023. The fair values of these warrants were estimated using the Black-Scholes option pricing model with the following weighted average assumptions: SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR FAIR VALUES WARRANTS March 31, 2022 March 10, 2021 Risk free interest rate 2.17 % 0.28 % Expected volatility 98.41 % 150.88 % Expected life 0.96 2 Expected dividend yield 0 % 0 % On October 27, 2021, the Company purchased 50,000 common shares of a private company for USD$ 100,000 . Draganfly Inc. Notes to the Condensed Consolidated Interim Financial Statements For The Three Months Ended March 31, 2022 Expressed in Canadian Dollars (unaudited)

EQUIPMENT

EQUIPMENT	3 Months Ended
	Mar. 31, 2022
EQUIPMENT	11. EQUIPMENT SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT Computer Equipment Furniture and Equipment Leasehold Improvements Software Vehicles Total Cost Balance at January 1, 2021 $ 24,397 $ 171,606 $ 4,352 $ 29,967 $ 27,652 $ 257,974 Additions 29,713 170,866 - - 12,000 212,579 Revaluation - - - - (3,619 ) (3,619 ) Balance at December 31, 2021 $ 54,110 $ 342,472 $ 4,352 $ 29,967 $ 36,033 $ 466,934 Property, plant and equipment, cost, beginning balance $ 54,110 $ 342,472 $ 4,352 $ 29,967 $ 36,033 $ 466,934 Additions 21,517 1,681 - - - 23,198 Disposals (18,688 ) (36,100 ) (4,352 ) (29,967 ) - (89,107 ) Balance at March 31, 2022 $ 56,939 $ 308,053 $ - $ - $ 36,033 $ 401,025 Property, plant and equipment, cost, ending balance $ 56,939 $ 308,053 $ - $ - $ 36,033 $ 401,025 Accumulated depreciation Balance at January 1, 2021 $ 12,392 $ 59,963 $ 3,220 $ 22,496 $ 6,033 $ 104,104 Charge for the year 12,899 42,314 1,132 2,241 7,201 65,787 Balance at December 31, 2021 $ 25,291 $ 102,277 $ 4,352 $ 24,737 $ 13,234 $ 169,891 Accumulated depreciation Property, plant and equipment, beginning balance $ 25,291 $ 102,277 $ 4,352 $ 24,737 $ 13,234 $ 169,891 Charge for the period 8,614 6,838 - - 854 16,306 Disposals (15,920 ) (33,342 ) (4,352 ) (24,737 ) - (78,351 ) Balance at March 31, 2022 $ 17,985 $ 75,773 $ - $ - $ 14,088 $ 107,846 Accumulated depreciation Property, plant and equipment, ending balance $ 17,985 $ 75,773 $ - $ - $ 14,088 $ 107,846 Net book value: December 31, 2021 $ 28,819 $ 240,195 $ - $ 5,230 $ 22,799 $ 297,043 March 31, 2022 $ 38,954 $ 232,280 $ - $ - $ 21,945 $ 293,179 Property, plant and equipment, net $ 38,954 $ 232,280 $ - $ - $ 21,945 $ 293,179 Draganfly Inc. Notes to the Condensed Consolidated Interim Financial Statements For The Three Months Ended March 31, 2022 Expressed in Canadian Dollars (unaudited)

INTANGIBLE ASSETS AND GOODWILL

INTANGIBLE ASSETS AND GOODWILL	3 Months Ended
	Mar. 31, 2022
INTANGIBLE ASSETS AND GOODWILL	12. INTANGIBLE ASSETS AND GOODWILL SCHEDULE OF INTANGIBLE ASSETS AND GOODWILL Patents Customer Relationships Brand Software Goodwill Total Cost Balance at January 1, 2021 $ 41,931 $ 197,000 $ - $ 119,000 $ 2,166,563 $ 2,524,494 Intangible assets acquired in the Transaction - - 23,000 433,000 8,353,609 8,809,609 Impairment of Goodwill - - - - (4,579,763 ) (4,579,763 ) Balance at December 31, 2021 $ 41,931 $ 197,000 $ 23,000 $ 552,000 $ 5,940,409 $ 6,754,340 Intangible assets and goodwill, cost, beginning balance $ 41,931 $ 197,000 $ 23,000 $ 552,000 $ 5,940,409 $ 6,754,340 Foreign exchange translation - - (330 ) (6,216 ) (54,176 ) (60,722 ) Balance at December 31, 2021 $ 41,931 $ 197,000 $ 22,670 $ 545,784 $ 5,886,233 $ 6,693,618 Intangible assets and goodwill, cost, ending balance $ 41,931 $ 197,000 $ 22,670 $ 545,784 $ 5,886,233 $ 6,693,618 Accumulated amortization Balance at January 1, 2021 $ 41,931 $ 26,267 $ - $ 15,866 $ - $ 84,064 Change for the year - 34,147 3,450 98,369 - 135,966 Balance at December 31, 2021 41,931 60,414 3,450 114,235 - 220,030 Accumulated amortization, beginning balance 41,931 60,414 3,450 114,235 - 220,030 Change for the period - 6,289 1,149 36,562 - 44,540 Foreign exchange translation - - (65 ) (1,544 ) - (1,609 ) Balance at December 31, 2021 $ 41,931 $ 67,243 $ 4,534 $ 149,253 $ - $ 262,961 Accumulated amortization, ending balance $ 41,931 $ 67,243 $ 4,534 $ 149,253 $ - $ 262,961 Net book value: December 31, 2021 $ - $ 136,586 $ 19,550 $ 437,765 $ 5,940,409 $ 6,534,310 March 31, 2022 $ - $ 129,757 $ 18,136 $ 396,531 $ 5,886,233 $ 6,430,657 Intangible assets and goodwill, net $ - $ 129,757 $ 18,136 $ 396,531 $ 5,886,233 $ 6,430,657 Brand On March 25, 2021, the Company acquired the assets of Vital (note 5) and assigned $ 23,000 Software On March 25, 2021, the Company acquired the assets of Vital and assigned $ 433,000 Goodwill On April 30, 2020, the Company acquired a 100 2,166,563 On March 25, 2021, the Company acquired the assets of Vital, which included goodwill. Goodwill was valued at $ 8,353,609 On December 31, 2021 the Company performed its annual goodwill impairment test on Vital and Dronelogics. The Company determined the recoverable amount based on a value in use calculation using the following key assumptions: ● 5 year post tax cash flow projections expected to be generated based on a financial forecast with a terminal growth rate of 2 ● Budgeted cash flows calculated using a weighted average revenue EBITDA margin of 14 42 ● Cash flows were discounted at the weighted average cost of capital of 17 24 Based on the annual goodwill impairment test, the Company deemed that the goodwill for Vital required impairment, as such the Company recorded an impairment of $ 4,579,763 Draganfly Inc. Notes to the Condensed Consolidated Interim Financial Statements For The Three Months Ended March 31, 2022 Expressed in Canadian Dollars (unaudited) 12. INTANGIBLE ASSETS AND GOODWILL (CONT’D) The most sensitive inputs to the value in use model are the growth and discount rates. All else being equal: ● A 10 597,100 570,133 Changing the above assumption would result in an impairment for Dronelogics, and would result in additional impairment for Vital. The key assumptions used in the calculations of the recoverable amounts include sales growth per year, changes in cost of sales and capital expenditures based on internal forecasts.

RIGHT OF USE ASSETS

RIGHT OF USE ASSETS	3 Months Ended
	Mar. 31, 2022
RIGHT OF USE ASSETS	13. RIGHT OF USE ASSETS SCHEDULE OF RIGHT OF USE ASSETS Total Cost Balance at December 31, 2020 $ 242,967 Additions 447,242 Lease removal (7,092 ) Balance at December 31, 2021 $ 683,117 Right of use assets, cost, beginning $ 683,117 Additions - Balance at March 31, 2022 $ 683,117 Right of use assets, cost, ending $ 683,117 Accumulated depreciation Balance at December 31, 2020 $ 98,548 Charge for the year 109,311 Historical correction 7,152 Balance at December 31, 2021 $ 215,011 Accumulated amortization, beginning $ 215,011 Charge for the period 30,840 Balance at March 31, 2022 $ 245,851 Accumulated amortization, ending $ 245,851 Net book value: December 31, 2021 $ 468,106 March 31, 2022 $ 437,266 Right of use assets, net $ 437,266 Draganfly Inc. Notes to the Condensed Consolidated Interim Financial Statements For The Three Months Ended March 31, 2022 Expressed in Canadian Dollars (unaudited)

LEASE LIABILITY

LEASE LIABILITY	3 Months Ended
	Mar. 31, 2022
Disclosure of maturity analysis of operating lease payments [abstract]
LEASE LIABILITY	14. LEASE LIABILITY The Company leases certain assets under lease agreements. The lease liabilities consist of leases of facilities and vehicles with terms ranging from one to five years. The leases are calculated using incremental borrowing rates ranging from 7.5% to 10.5% SCHEDULE OF OPERATING LEASE LIABILITIES Total Balance at December 31, 2020 $ 158,124 Additions 440,675 Interest expense 26,964 Lease payments (128,995 ) Lease removal (7,645 ) Balance at December 31, 2021 $ 489,123 Lease liabilities, beginning of period $ 489,123 Interest expense 10,927 Lease payments (36,583 ) Balance at March 31, 2022 $ 463,467 Lease liabilities, end of period $ 463,467 Which consists of: Current lease liability $ 115,269 Non-current lease liability 348,198 Balance at March 31, 2022 $ 463,467 Lease liabilities $ 463,467 SCHEDULE OF OPERATING MATURITY ANALYSIS Maturity analysis Total Less than one year $ 150,276 One to three years 238,347 Four to five years 162,340 Greater than five years - Total undiscounted lease liabilities 550,963 Amount representing implicit interest (87,496 ) Lease liability $ 463,467

TRADE PAYABLES AND ACCRUED LIAB

TRADE PAYABLES AND ACCRUED LIABILITIES	3 Months Ended
	Mar. 31, 2022
TRADE PAYABLES AND ACCRUED LIABILITIES	15. TRADE PAYABLES AND ACCRUED LIABILITIES SCHEDULE OF TRADE PAYABLES AND ACCRUED LIABILITIES March 31, 2022 December 31, 2021 Trade accounts payable $ 415,814 $ 362,890 Accrued liabilities 219,465 402,540 Government grant payable 33,709 33,709 Trade payables and accrued liabilities $ 668,988 $ 799,139 Draganfly Inc. Notes to the Condensed Consolidated Interim Financial Statements For The Three Months Ended March 31, 2022 Expressed in Canadian Dollars (unaudited)

LOANS PAYABLE

LOANS PAYABLE	3 Months Ended
	Mar. 31, 2022
LOANS PAYABLE	16. LOANS PAYABLE SCHEDULE OF LOANS PAYABLE March 31, 2022 December 31, 2021 Opening balance $ 93,317 $ 97,916 Issuance of loans payable - 60,000 Fair value adjustment - (24,576 ) Repayment of loans payable (1,687 ) (44,428 ) Accretion expense 1,276 4,405 Ending balance $ 92,906 $ 93,317 SCHEDULE OF LOANS Start Date Maturity Date Rate Carrying Value March 31, 2022 Carrying Value December 31, 2021 CEBA 2020-05-19 2022-12-31 0 % $ 38,021 $ 37,384 CEBA 2021-04-23 2022-12-31 0 % 38,021 37,383 Vehicle loan 2019-08-30 2024-09-11 6.99 % 16,864 18,550 Total $ 92,906 $ 93,317 On May 19, 2020, Dronelogics received a $ 40,000 CEBA loan. This loan is currently interest-free and 25% of the loan, up to $ 10,000 5% 20,000 10,000 On April 23, 2021, Draganfly Innovations Inc. received a $ 60,000 20,000 5% The CEBA loans are unsecured and the vehicle loan is secured by the vehicle. Draganfly Inc. Notes to the Condensed Consolidated Interim Financial Statements For The Three Months Ended March 31, 2022 Expressed in Canadian Dollars (unaudited)

SHARE CAPITAL

SHARE CAPITAL	3 Months Ended
	Mar. 31, 2022
SHARE CAPITAL	17. SHARE CAPITAL Authorized share capital Unlimited number of common shares without par value. Issued share capital During the three months ended March 31, 2022, ● The Company issued 16,538 74,227 ● The Company issued 12,500 26,875 During the year ended December 31, 2021, ● The Company issued 1,580,525 3,951,312 ● The Company issued 149,999 ● The Company issued 392,999 987,248 ● The Company issued 15,000 ● The Company issued 6,488,691 18,815,485 Each unit is comprised of one common share and one share purchase warrant. These warrants had a fair value of $0.57 USD allocated to them, have an exercise price of $3.55 USD per warrant, each convert to one common share, and have a life of two years 8,261,511 ● The Company issued 1,200,000 Each unit is comprised of one common share and one warrant. These warrants have an exercise price of $13.35 per warrant, each convert to one common share, and have a life of two years. ● The Company issued 5,095,966 25,538,213 ● The Company issued 359,009 978,478 ● The Company issued 298,661 ● The Company issued 12,500 26,875 ● The Company issued 356,901 Stock Options The Company has adopted an incentive share compensation plan, which provides that the Board of Directors of the Company may from time to time, in its discretion, and in accordance with the CSE requirements, grant to directors, officers, employees, and technical consultants to the Company, non-transferable stock options to purchase common shares. The total number of common shares reserved and available for grant and issuance pursuant to this plan shall not exceed 20% (in the aggregate) of the issued and outstanding common shares from time to time. The number of options awarded and underlying vesting conditions are determined by the Board of Directors in its discretion. As at March 31, 2022, the Company had the following options outstanding and exercisable: SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE Grant Date Expiry Date Exercise Price Remaining Contractual Life (years) Number of Options Outstanding Number of Options Exercisable October 30, 2019 October 30, 2029 $ 2.50 7.59 296,665 296,665 November 19, 2019 November 19, 2029 $ 2.50 7.64 50,000 50,000 April 30, 2020 April 30, 2030 $ 2.50 8.09 87,000 78,666 April 30, 2020 April 30, 2030 $ 3.85 8.09 110,000 70,000 July 3, 2020 July 3, 2025 $ 3.20 3.26 200,000 166,666 November 24, 2020 November 24, 2030 $ 2.50 8.66 32,000 21,000 February 2, 2021 February 2, 2031 $ 13.20 8.85 30,000 20,000 March 8, 2021 March 8, 2026 $ 13.90 3.94 10,000 7,500 April 27, 2021 April 27, 2031 $ 10.15 8.98 182,000 - September 9, 2021 September 9, 2026 $ 4.84 4.44 25,826 - 1,023,491 710,497 Draganfly Inc. Notes to the Condensed Consolidated Interim Financial Statements For The Three Months Ended March 31, 2022 Expressed in Canadian Dollars (unaudited) 17. SHARE CAPITAL (CONT’D) Stock options (cont’d) SUMMARY OF CHANGES IN STOCK OPTIONS Number of Options Weighted Average Exercise Price Outstanding, December 31, 2020 1,193,659 $ 2.75 Forfeited (405,494 ) 2.50 Granted 247,826 10.12 Outstanding, December 31, 2021 1,035,991 $ 4.60 Exercised (12,500 ) 2.50 Outstanding, March 31, 2022 1,023,491 $ 3.22 No During the year ended December 31, 2021, ● The Company granted 30,000 13.20 10 years ● The Company granted 10,000 13.90 5 years ● The Company granted 182,000 10.15 10 years ● The Company granted 25,826 4.84 5 years During the three months ended March 31, 2022, the Company recorded $ 297,566 516,351 SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS Three months ended March 31, 2022 2021 Risk free interest rate 2.38 % 0.69% 1.40 % Expected volatility 69.83 % 111.87% 113.16 % Expected life 5 years 5 years Expected dividend yield 0 % 0 % Exercise price $ 13.90 $ 13.20 13.90 Volatility is calculated using the historical volatility method based on a comparative company’s stock price. Restricted Share Units The Company has adopted an incentive share compensation plan, which provides that the Board of Directors of the Company may from time to time, in its discretion, and in accordance with the Exchange requirements, grant to directors, officers, employees, and technical consultants to the Company, restricted stock units (RSUs). The number of RSUs awarded and underlying vesting conditions are determined by the Board of Directors in its discretion. RSUs will have a 3-year vesting period following the award date. The total number of common shares reserved and available for grant and issuance pursuant to this plan, and the total number of Restricted Share Units that may be awarded pursuant to this plan, shall not exceed 20% (in the aggregate) of the issued and outstanding common shares from time to time. Draganfly Inc. Notes to the Condensed Consolidated Interim Financial Statements For The Three Months Ended March 31, 2022 Expressed in Canadian Dollars (unaudited) 17. SHARE CAPITAL (CONT’D) SUMMARY OF CHANGES IN RESTRICTED STOCK UNITS As at March 31, 2022, the Company had the following RSUs outstanding: Number of RSUs Outstanding, December 31, 2020 614,666 Vested (448,660 ) Issued 348,826 Outstanding, December 31, 2021 514,832 Issued - Outstanding, March 31, 2022 514,832 The Company did not issue any RSU’s for the three months ended March 31, 2022. During the year ended December 31, 2021, 323,661 124,999 348,826 During the three months ended March 31, 2022, the Company recorded share-based payment expense of $ 345,759 533,515 Warrants During the years ended December 31, 2021 and 2020, the Company issued warrants (“USD Warrants”) with a USD exercise price. Being in a foreign currency that is not the Company’s functional currency, these USD Warrants are required to be recorded as a financial liability and not as equity. As a financial liability, these USD Warrants are revalued on a quarterly basis to fair market value with the change in fair value being recorded profit or loss. The initial fair value of these USD Warrants was parsed out from equity and recorded as a financial liability. To reach a fair value of the USD Warrants, a Black Scholes calculation is used, calculated in USD as the Company also trades on the Nasdaq. The Black Scholes value per USD Warrant is then multiplied by the number of outstanding warrants and then multiplied by the foreign exchange rate at the end of the period from the Bank of Canada. Warrant Derivative Liability SCHEDULE OF WARRANT DERIVATIVE LIABILITY Balance at January 1, 2021 $ 748,634 Warrant issuance 8,261,511 Exercised (98,048 ) Change in fair value of warrants outstanding (4,046,325 ) Balance at December 31, 2021 $ 4,865,772 Exercised (74,227 ) Change in fair value of warrants outstanding 1,022,501 Warrant Balance at March 31, 2022 $ 5,814,046 Derivative liability Warrants $ 5,814,046 Contingent consideration (note 5) 976,816 Derivative liability at March 31, 2022 $ 6,790,862 Draganfly Inc. Notes to the Condensed Consolidated Interim Financial Statements For The Three Months Ended March 31, 2022 Expressed in Canadian Dollars (unaudited) 17. SHARE CAPITAL (CONT’D) Warrants (cont’d) Details of these warrants and their fair values are as follows: SCHEDULE OF WARRANTS AND FAIR VALUE OUTSTANDING Issue Date Exercise Price Number of Warrants Outstanding at March 31, 2022 Fair Value at March 31, 2022 Number of Warrants Outstanding at December 31, 2021 Fair Value at December 31, 2021 November 30, 2020 US$ 3.55 481,484 $ 353,777 482,425 $ 182,262 February 5, 2021 US$ 3.55 1,319,675 1,076,840 1,323,275 951,226 March 5, 2021 US$ 3.55 5,142,324 4,383,429 5,154,321 3,731,284 6,943,483 $ 5,814,046 6,960,021 $ 4,864,772 T SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR WARRANTS March 31, 2022 December 31, 2021 Risk free interest rate 2.17 % 0.23% 0.95 % Expected volatility 72.74% 126.97 % 70.95% 144.59 % Expected life 0.67 2.46 2 3 Expected dividend yield 0 % 0 % Volatility is calculated using the historical volatility method. During the year ended December 31, 2020, the Company amended the expiry date of the November 5, 2019 warrants from November 5, 2020 to November 5, 2021 provided that 25% of the warrants were exercised by October 21, 2020 and 25% were exercised by May 5, 2021. SUMMARY OF CHANGES IN WARRANTS Number of Warrants Weighted Average Exercise Price Outstanding, December 31, 2020 2,416,864 $ 2.95 Exercised (1,939,534 ) 2.54 Forfeited (6,000 ) 2.50 Issued 7,943,489 5.10 Outstanding, December 31, 2021 8,414,819 $ 4.99 Exercised (16,538 ) 4.44 Outstanding, March 31, 2022 8,398,281 $ 4.99 As at March 31, 2022, the Company had the following warrants outstanding: SCHEDULE OF WARRANTS OUTSTANDING Date issued Expiry date Exercise price Number of warrants outstanding November 30, 2020 November 30, 2022 3.55 481,484 February 5, 2021 February 5, 2023 3.55 1,319,675 March 5, 2021 March 5, 2023 US$ 3.55 5,142,324 March 22, 2021 March 22, 2023 13.35 1,200,000 July 29, 2021 July 29, 2024 US$ 5.00 250,000 September 14, 2021 September 14, 2024 US$ 5.00 4,798 8,398,281 Draganfly Inc. Notes to the Condensed Consolidated Interim Financial Statements For The Three Months Ended March 31, 2022 Expressed in Canadian Dollars (unaudited) 17. SHARE CAPITAL (CONT’D) Warrants (cont’d) The weighted average remaining contractual life of warrants outstanding as of March 31, 2022, was 0.96 years (December 31, 2021 – 1.20 years). Of 1,200,000 900,000

REVENUE

REVENUE	3 Months Ended
	Mar. 31, 2022
REVENUE	18. REVENUE The Company sub-classifies revenue within the following components: product revenue and services revenue. Product revenue comprises of sales of internally assembled multi-rotor helicopters, industrial aerial video systems, civilian small unmanned aerial systems or vehicles, and wireless video systems. Services revenue consists of fees charged for custom engineering, drone as a service work, and training and simulation consulting. SCHEDULE OF PRODUCT AND SERVICE REVENUE For the period ended March 31, 2022 2021 Product sales $ 1,637,716 $ 1,129,307 Drone service 406,096 409,963 Services 750 466 Revenue $ 2,044,562 $ 1,539,736 Geographic revenue segmentation is as follows: SCHEDULE OF GEOGRAPHIC REVENUE For the three months ended March 31, 2022 2021 For the three months ended March 31, 2022 2021 Canada $ 1,467,830 $ 769,380 United States 576,732 770,356 Revenue $ 2,044,562 $ 1,539,736 Draganfly Inc. Notes to the Condensed Consolidated Interim Financial Statements For The Three Months Ended March 31, 2022 Expressed in Canadian Dollars (unaudited) 18. REVENUE (CONT’D) Non-current assets for each geographic segment are as follows: SCHEDULE OF OPERATING SEGMENTS As at March 31, 2022 Canada United States As at March 31, 2022 Canada United States Goodwill $ 2,166,564 $ 3,719,669 Property and equipment 293,179 - Intangible assets 208,139 336,285 Investments 257,817 - Notes receivable 786,055 1,143,432 Right of use assets 437,266 - Total assets $ 4,149,020 $ 5,199,386

OFFICE AND MISCELLANEOUS

OFFICE AND MISCELLANEOUS	3 Months Ended
	Mar. 31, 2022
OFFICE AND MISCELLANEOUS	19. OFFICE AND MISCELLANEOUS SCHEDULE OF OFFICE AND MISCELLANEOUS EXPENSES For the three months ended March 31, 2022 2021 Advertising, Marketing, and Investor Relations $ 1,159,773 $ 2,095,092 Compliance fees 47,380 115,734 Contract Work 214,848 34,077 Other 185,836 80,883 Office and Miscellaneous Expenses $ 1,607,837 $ 2,325,786

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	3 Months Ended
	Mar. 31, 2022
RELATED PARTY TRANSACTIONS	20. RELATED PARTY TRANSACTIONS Key management personnel include those persons having authority and responsibility for planning, directing and controlling the activities of the Company as a whole. The Company has determined that key management personnel consist of members of the Company’s Board of Directors and corporate officers. On August 1, 2019, the Company entered in a business services agreement (the “Agreement”) with Business Instincts Group (“BIG”), a company that Cameron Chell, CEO and director has a material interest in that he previously controlled, to provide: corporate development and governance, strategic facilitation and management, general business services, office space, corporate business development video content, website redesign and management, and online visibility management. The services are provided by a team of up to six consultants and the costs of all charges are based on the fees set in the Agreement and are settled on a monthly basis. The Company records these charges under Professional Fees. For the three months ended March 31, 2022, the company incurred fees of $ 125,732 compared to $ 43,500 in 2021. As at March 31, 2022, the Company was indebted to this company in the amount of $ nil (December 31, 2021 - $ nil ). On October 1, 2019, the Company entered into an independent consultant agreement (“Consultant Agreement”) with 1502372 Alberta Ltd, a company controlled by Cameron Chell, CEO and director, to provide executive consulting services to the Company. The costs of all charges are based on the fees set in the Consultant Agreement and are settled on a monthly basis. The Company records these charges under Professional Fees. For the three months ended March 31, 2022, the Company incurred fees of $ 100,000 53,764 nil nil On July 3, 2020, the Company entered into an executive consultant agreement (“Executive Agreement”) with Scott Larson, a director of the Company, to provide executive consulting services, as President, to the Company. The costs of all charges are based on the fees set in the Executive Agreement and are settled on a monthly basis. The Company records these charges under Professional Fees. For the three months ended March 31, 2022, the Company incurred fees of $ 62,500 44,123 nil nil Draganfly Inc. Notes to the Condensed Consolidated Interim Financial Statements For The Three Months Ended March 31, 2022 Expressed in Canadian Dollars (unaudited) 20. RELATED PARTY TRANSACTIONS (CONT’D) Trade payables and accrued liabilities: As at March 31, 2022, the Company had $ nil nil Key management compensation Key management includes the Company’s directors and members of the executive management team. Compensation awarded to key management for the three months ended March 31, 2022 and 2021 included: SCHEDULE OF KEY MANAGEMENT TRANSACTIONS For the three months ended March 31, 2022 2021 Director fees $ 107,446 $ 86,691 Management fees paid to a company controlled by CEO and director 100,000 53,764 Management fees paid to a company controlled by the President and director 62,500 44,123 Management fees paid to a company controlled by a former director 82,993 45,000 Salaries 127,565 122,976 Share-based payments 322,083 680,097 Total $ 802,587 1,032,651

SUPPLEMENTAL CASH FLOW DISCLOSU

SUPPLEMENTAL CASH FLOW DISCLOSURES	3 Months Ended
	Mar. 31, 2022
Supplemental Cash Flow Disclosures
SUPPLEMENTAL CASH FLOW DISCLOSURES	21. SUPPLEMENTAL CASH FLOW DISCLOSURES During the year ended December 31, 2021: - The Company issued 15,000 - The Company issued 1,200,000 13.35 - The Company issued 356,901 - The Company recorded a change in fair value of investments of $ 332,640

SUBSEQUENT EVENT

SUBSEQUENT EVENT	3 Months Ended
	Mar. 31, 2022
SUBSEQUENT EVENT	22. SUBSEQUENT EVENT Subsequent to the three months ending March 31, 2022, the Company signed a forbearance agreement with one of the holders of notes receivable (note 8) to bring the note out of default. Terms of the agreement required the recipient to repay $ 450,000 771,260 450,000

BASIS OF PREPARATION (Tables)

BASIS OF PREPARATION (Tables)	3 Months Ended
	Mar. 31, 2022
SCHEDULE OF RESULTS OF OPERATIONS	The consolidated financial statements include the accounts and results of operations of the Company and its wholly owned subsidiaries listed in the following table: SCHEDULE OF RESULTS OF OPERATIONS Name of Subsidiary Place of Incorporation Ownership Interest Draganfly Innovations Inc. Canada 100 % Draganfly Innovations USA, Inc. US 100 % Dronelogics Systems Inc. Canada 100 %

RESTATEMENT TO PREVIOUS PERIO_2

RESTATEMENT TO PREVIOUS PERIODS (Tables)	3 Months Ended
	Mar. 31, 2022
Restatement To Previous Periods
SCHEDULE OF ADJUSTMENTS TO COMPARATIVE FINANCIAL INFORMATION	SCHEDULE OF ADJUSTMENTS TO COMPARATIVE FINANCIAL INFORMATION As at March 31, 2021 Amounts before restatement Restatement Amounts restated Condensed consolidated interim statement of loss Weighted average number of shares outstanding – basic & diluted 21,070,046 (90,000 ) 20,980,046 Net loss per share – basic and diluted $ (2.15 ) $ - $ (2.15 ) For the three months ended March 31, 2021 Condensed consolidated interim statement of changes in shareholders’ equity $ $ $ Share capital 75,459,911 (11,916,001 ) 63,543,910 Equity reserve 5,955,327 (1,831,607 ) 4,123,720 Balance at March 31, 2021 381,485 (13,747,308 ) (13,366,123 )

VITAL ACQUISITION (Tables)

VITAL ACQUISITION (Tables)	3 Months Ended
	Mar. 31, 2022
Vital Acquisition
SCHEDULE OF CONTINGENT CONSIDERATION	SCHEDULE OF CONTINGENT CONSIDERATION Contingent consideration Fair value of contingent consideration $ 4,797,717 Change in fair value of contingent consideration (4,103,487 ) Contingent consideration at December 31, 2021 694,230 Change in fair value of contingent consideration 282,587 Contingent consideration at March 31, 2022 (note 17) $ 976,816
SCHEDULE OF PURCHASE PRICE ALLOCATION FOR VITAL INTELLIGENCE	SCHEDULE OF PURCHASE PRICE ALLOCATION FOR VITAL INTELLIGENCE Number of units of Draganfly Inc. 578,248 Fair value of units $ 14.43 Fair value of units of Draganfly Inc. $ 8,342,966 Cash portion of purchase price 466,643 Total $ 8,809,609 Identifiable intangible assets Brand $ 23,000 Software 433,000 Identifiable intangible assets 456,000 Goodwill 8,353,609 Total consideration $ 8,809,609

CASH AND CASH EQUIVALENTS (Tabl

CASH AND CASH EQUIVALENTS (Tables)	3 Months Ended
	Mar. 31, 2022
SCHEDULE OF CASH AND CASH EQUIVALENTS	SCHEDULE OF CASH AND CASH EQUIVALENTS March 31, 2022 December 31, 2021 Cash held in banks $ 19,231,149 $ 22,729,212 Guaranteed investment certificates 345,753 346,501 Cash and Cash Equivalents $ 19,576,902 $ 23,075,713

RECEIVABLES (Tables)

RECEIVABLES (Tables)	3 Months Ended
	Mar. 31, 2022
Schedule Of Amounts Receivable
SCHEDULE OF AMOUNTS RECEIVABLE	SCHEDULE OF AMOUNTS RECEIVABLE March 31, 2022 December 31, 2021 Trade accounts receivable $ 1,458,502 $ 951,314 Corporate taxes receivable 182,820 182,820 GST receivable 310,123 $ 272,993 Trade and other receivables $ 1,951,445 $ 1,407,127

INVENTORY (Tables)

INVENTORY (Tables)	3 Months Ended
	Mar. 31, 2022
SCHEDULE OF INVENTORIES	SCHEDULE OF INVENTORIES March 31, 2022 December 31, 2021 Finished goods $ 2,997,812 $ 3,017,363 Parts 367,361 373,459 Inventories $ 3,365,173 $ 3,390,822
SCHEDULE OF COST OF SALES	SCHEDULE OF COST OF SALES March 31, 2022 March 31, 2021 Inventory $ 1,161,511 $ 784,095 Consulting and services 64,833 162,393 Other 2,068 78,241 Cost of sales $ 1,228,412 $ 1,024,729

NOTES RECEIVABLE (Tables)

NOTES RECEIVABLE (Tables)	3 Months Ended
	Mar. 31, 2022
Notes Receivable
DISCLOSURE OF NOTES RECEIVABLE	DISCLOSURE OF NOTES RECEIVABLE Start Date Maturity Date Rate Principal Interest Accretion Impairment recovery Total Note 1 (1) 2021-04-21 2022-10-21 0 % $ 178,223 $ - $ 3,488 $ - $ 181,711 Note 2 (1) 2021-09-22 2024-09-22 5 % 943,544 11,555 6,622 - 961,721 Note 3 2021-11-17 2022-04-26 8 % - 14,795 - 771,260 786,055 Total $ 1,121,767 $ 26,350 $ 10,110 $ 771,260 $ 1,929,487 (1) These notes are denominated in US dollars and are converted to Canadian dollars at the reporting date. Current assets Non-Current assets Note 1 $ 181,711 $ - Note 2 - 961,721 Note 3 786,055 - Notes receivable $ 967,766 $ 961,721

PREPAIDS (Tables)

PREPAIDS (Tables)	3 Months Ended
	Mar. 31, 2022
SCHEDULE OF PREPAID EXPENSES AND DEPOSITS	SCHEDULE OF PREPAID EXPENSES AND DEPOSITS March 31, 2022 December 31, 2021 Insurance $ 1,464,830 $ 2,938,246 Prepaid director fees 107,778 107,763 Prepaid interest 2,699 6,969 Prepaid marketing services 1,173,062 1,638,179 Prepaid rent 10,255 - Prepaid subscriptions 6,611 35,687 Deposits 587,317 768,033 Prepaid expenses and deposits $ 3,352,552 $ 5,494,877

INVESTMENTS (Tables)

INVESTMENTS (Tables)	3 Months Ended
	Mar. 31, 2022
Disclosure of detailed information about investment property [abstract]
SCHEDULE OF INVESTMENTS	SCHEDULE OF INVESTMENTS Balance at December 31, 2021 $ 291,066 Change in fair value (33,249 ) Balance at December 31, 2021 $ 257,817 Fair value of investments is comprised of: Public company shares $ 128,571 Public company warrants 4,286 Private company shares 124,960 Balance at December 31, 2021 $ 257,817
SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR FAIR VALUES WARRANTS	The fair values of these warrants were estimated using the Black-Scholes option pricing model with the following weighted average assumptions: SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR FAIR VALUES WARRANTS March 31, 2022 March 10, 2021 Risk free interest rate 2.17 % 0.28 % Expected volatility 98.41 % 150.88 % Expected life 0.96 2 Expected dividend yield 0 % 0 %

EQUIPMENT (Tables)

EQUIPMENT (Tables)	3 Months Ended
	Mar. 31, 2022
SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT	SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT Computer Equipment Furniture and Equipment Leasehold Improvements Software Vehicles Total Cost Balance at January 1, 2021 $ 24,397 $ 171,606 $ 4,352 $ 29,967 $ 27,652 $ 257,974 Additions 29,713 170,866 - - 12,000 212,579 Revaluation - - - - (3,619 ) (3,619 ) Balance at December 31, 2021 $ 54,110 $ 342,472 $ 4,352 $ 29,967 $ 36,033 $ 466,934 Property, plant and equipment, cost, beginning balance $ 54,110 $ 342,472 $ 4,352 $ 29,967 $ 36,033 $ 466,934 Additions 21,517 1,681 - - - 23,198 Disposals (18,688 ) (36,100 ) (4,352 ) (29,967 ) - (89,107 ) Balance at March 31, 2022 $ 56,939 $ 308,053 $ - $ - $ 36,033 $ 401,025 Property, plant and equipment, cost, ending balance $ 56,939 $ 308,053 $ - $ - $ 36,033 $ 401,025 Accumulated depreciation Balance at January 1, 2021 $ 12,392 $ 59,963 $ 3,220 $ 22,496 $ 6,033 $ 104,104 Charge for the year 12,899 42,314 1,132 2,241 7,201 65,787 Balance at December 31, 2021 $ 25,291 $ 102,277 $ 4,352 $ 24,737 $ 13,234 $ 169,891 Accumulated depreciation Property, plant and equipment, beginning balance $ 25,291 $ 102,277 $ 4,352 $ 24,737 $ 13,234 $ 169,891 Charge for the period 8,614 6,838 - - 854 16,306 Disposals (15,920 ) (33,342 ) (4,352 ) (24,737 ) - (78,351 ) Balance at March 31, 2022 $ 17,985 $ 75,773 $ - $ - $ 14,088 $ 107,846 Accumulated depreciation Property, plant and equipment, ending balance $ 17,985 $ 75,773 $ - $ - $ 14,088 $ 107,846 Net book value: December 31, 2021 $ 28,819 $ 240,195 $ - $ 5,230 $ 22,799 $ 297,043 March 31, 2022 $ 38,954 $ 232,280 $ - $ - $ 21,945 $ 293,179 Property, plant and equipment, net $ 38,954 $ 232,280 $ - $ - $ 21,945 $ 293,179

INTANGIBLE ASSETS AND GOODWILL

INTANGIBLE ASSETS AND GOODWILL (Tables)	3 Months Ended
	Mar. 31, 2022
SCHEDULE OF INTANGIBLE ASSETS AND GOODWILL	SCHEDULE OF INTANGIBLE ASSETS AND GOODWILL Patents Customer Relationships Brand Software Goodwill Total Cost Balance at January 1, 2021 $ 41,931 $ 197,000 $ - $ 119,000 $ 2,166,563 $ 2,524,494 Intangible assets acquired in the Transaction - - 23,000 433,000 8,353,609 8,809,609 Impairment of Goodwill - - - - (4,579,763 ) (4,579,763 ) Balance at December 31, 2021 $ 41,931 $ 197,000 $ 23,000 $ 552,000 $ 5,940,409 $ 6,754,340 Intangible assets and goodwill, cost, beginning balance $ 41,931 $ 197,000 $ 23,000 $ 552,000 $ 5,940,409 $ 6,754,340 Foreign exchange translation - - (330 ) (6,216 ) (54,176 ) (60,722 ) Balance at December 31, 2021 $ 41,931 $ 197,000 $ 22,670 $ 545,784 $ 5,886,233 $ 6,693,618 Intangible assets and goodwill, cost, ending balance $ 41,931 $ 197,000 $ 22,670 $ 545,784 $ 5,886,233 $ 6,693,618 Accumulated amortization Balance at January 1, 2021 $ 41,931 $ 26,267 $ - $ 15,866 $ - $ 84,064 Change for the year - 34,147 3,450 98,369 - 135,966 Balance at December 31, 2021 41,931 60,414 3,450 114,235 - 220,030 Accumulated amortization, beginning balance 41,931 60,414 3,450 114,235 - 220,030 Change for the period - 6,289 1,149 36,562 - 44,540 Foreign exchange translation - - (65 ) (1,544 ) - (1,609 ) Balance at December 31, 2021 $ 41,931 $ 67,243 $ 4,534 $ 149,253 $ - $ 262,961 Accumulated amortization, ending balance $ 41,931 $ 67,243 $ 4,534 $ 149,253 $ - $ 262,961 Net book value: December 31, 2021 $ - $ 136,586 $ 19,550 $ 437,765 $ 5,940,409 $ 6,534,310 March 31, 2022 $ - $ 129,757 $ 18,136 $ 396,531 $ 5,886,233 $ 6,430,657 Intangible assets and goodwill, net $ - $ 129,757 $ 18,136 $ 396,531 $ 5,886,233 $ 6,430,657

RIGHT OF USE ASSETS (Tables)

RIGHT OF USE ASSETS (Tables)	3 Months Ended
	Mar. 31, 2022
SCHEDULE OF RIGHT OF USE ASSETS	SCHEDULE OF RIGHT OF USE ASSETS Total Cost Balance at December 31, 2020 $ 242,967 Additions 447,242 Lease removal (7,092 ) Balance at December 31, 2021 $ 683,117 Right of use assets, cost, beginning $ 683,117 Additions - Balance at March 31, 2022 $ 683,117 Right of use assets, cost, ending $ 683,117 Accumulated depreciation Balance at December 31, 2020 $ 98,548 Charge for the year 109,311 Historical correction 7,152 Balance at December 31, 2021 $ 215,011 Accumulated amortization, beginning $ 215,011 Charge for the period 30,840 Balance at March 31, 2022 $ 245,851 Accumulated amortization, ending $ 245,851 Net book value: December 31, 2021 $ 468,106 March 31, 2022 $ 437,266 Right of use assets, net $ 437,266

LEASE LIABILITY (Tables)

LEASE LIABILITY (Tables)	3 Months Ended
	Mar. 31, 2022
Disclosure of maturity analysis of operating lease payments [abstract]
SCHEDULE OF OPERATING LEASE LIABILITIES	SCHEDULE OF OPERATING LEASE LIABILITIES Total Balance at December 31, 2020 $ 158,124 Additions 440,675 Interest expense 26,964 Lease payments (128,995 ) Lease removal (7,645 ) Balance at December 31, 2021 $ 489,123 Lease liabilities, beginning of period $ 489,123 Interest expense 10,927 Lease payments (36,583 ) Balance at March 31, 2022 $ 463,467 Lease liabilities, end of period $ 463,467 Which consists of: Current lease liability $ 115,269 Non-current lease liability 348,198 Balance at March 31, 2022 $ 463,467 Lease liabilities $ 463,467
SCHEDULE OF OPERATING MATURITY ANALYSIS	SCHEDULE OF OPERATING MATURITY ANALYSIS Maturity analysis Total Less than one year $ 150,276 One to three years 238,347 Four to five years 162,340 Greater than five years - Total undiscounted lease liabilities 550,963 Amount representing implicit interest (87,496 ) Lease liability $ 463,467

TRADE PAYABLES AND ACCRUED LI_2

TRADE PAYABLES AND ACCRUED LIABILITIES (Tables)	3 Months Ended
	Mar. 31, 2022
SCHEDULE OF TRADE PAYABLES AND ACCRUED LIABILITIES	SCHEDULE OF TRADE PAYABLES AND ACCRUED LIABILITIES March 31, 2022 December 31, 2021 Trade accounts payable $ 415,814 $ 362,890 Accrued liabilities 219,465 402,540 Government grant payable 33,709 33,709 Trade payables and accrued liabilities $ 668,988 $ 799,139

LOANS PAYABLE (Tables)

LOANS PAYABLE (Tables)	3 Months Ended
	Mar. 31, 2022
SCHEDULE OF LOANS PAYABLE	SCHEDULE OF LOANS PAYABLE March 31, 2022 December 31, 2021 Opening balance $ 93,317 $ 97,916 Issuance of loans payable - 60,000 Fair value adjustment - (24,576 ) Repayment of loans payable (1,687 ) (44,428 ) Accretion expense 1,276 4,405 Ending balance $ 92,906 $ 93,317
SCHEDULE OF LOANS	SCHEDULE OF LOANS Start Date Maturity Date Rate Carrying Value March 31, 2022 Carrying Value December 31, 2021 CEBA 2020-05-19 2022-12-31 0 % $ 38,021 $ 37,384 CEBA 2021-04-23 2022-12-31 0 % 38,021 37,383 Vehicle loan 2019-08-30 2024-09-11 6.99 % 16,864 18,550 Total $ 92,906 $ 93,317

SHARE CAPITAL (Tables)

SHARE CAPITAL (Tables)	3 Months Ended
	Mar. 31, 2022
SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE	As at March 31, 2022, the Company had the following options outstanding and exercisable: SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE Grant Date Expiry Date Exercise Price Remaining Contractual Life (years) Number of Options Outstanding Number of Options Exercisable October 30, 2019 October 30, 2029 $ 2.50 7.59 296,665 296,665 November 19, 2019 November 19, 2029 $ 2.50 7.64 50,000 50,000 April 30, 2020 April 30, 2030 $ 2.50 8.09 87,000 78,666 April 30, 2020 April 30, 2030 $ 3.85 8.09 110,000 70,000 July 3, 2020 July 3, 2025 $ 3.20 3.26 200,000 166,666 November 24, 2020 November 24, 2030 $ 2.50 8.66 32,000 21,000 February 2, 2021 February 2, 2031 $ 13.20 8.85 30,000 20,000 March 8, 2021 March 8, 2026 $ 13.90 3.94 10,000 7,500 April 27, 2021 April 27, 2031 $ 10.15 8.98 182,000 - September 9, 2021 September 9, 2026 $ 4.84 4.44 25,826 - 1,023,491 710,497
SUMMARY OF CHANGES IN STOCK OPTIONS	SUMMARY OF CHANGES IN STOCK OPTIONS Number of Options Weighted Average Exercise Price Outstanding, December 31, 2020 1,193,659 $ 2.75 Forfeited (405,494 ) 2.50 Granted 247,826 10.12 Outstanding, December 31, 2021 1,035,991 $ 4.60 Exercised (12,500 ) 2.50 Outstanding, March 31, 2022 1,023,491 $ 3.22
SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS	SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS Three months ended March 31, 2022 2021 Risk free interest rate 2.38 % 0.69% 1.40 % Expected volatility 69.83 % 111.87% 113.16 % Expected life 5 years 5 years Expected dividend yield 0 % 0 % Exercise price $ 13.90 $ 13.20 13.90
SUMMARY OF CHANGES IN RESTRICTED STOCK UNITS	SUMMARY OF CHANGES IN RESTRICTED STOCK UNITS As at March 31, 2022, the Company had the following RSUs outstanding: Number of RSUs Outstanding, December 31, 2020 614,666 Vested (448,660 ) Issued 348,826 Outstanding, December 31, 2021 514,832 Issued - Outstanding, March 31, 2022 514,832
SCHEDULE OF WARRANT DERIVATIVE LIABILITY	SCHEDULE OF WARRANT DERIVATIVE LIABILITY Balance at January 1, 2021 $ 748,634 Warrant issuance 8,261,511 Exercised (98,048 ) Change in fair value of warrants outstanding (4,046,325 ) Balance at December 31, 2021 $ 4,865,772 Exercised (74,227 ) Change in fair value of warrants outstanding 1,022,501 Warrant Balance at March 31, 2022 $ 5,814,046 Derivative liability Warrants $ 5,814,046 Contingent consideration (note 5) 976,816 Derivative liability at March 31, 2022 $ 6,790,862
SCHEDULE OF WARRANTS AND FAIR VALUE OUTSTANDING	Details of these warrants and their fair values are as follows: SCHEDULE OF WARRANTS AND FAIR VALUE OUTSTANDING Issue Date Exercise Price Number of Warrants Outstanding at March 31, 2022 Fair Value at March 31, 2022 Number of Warrants Outstanding at December 31, 2021 Fair Value at December 31, 2021 November 30, 2020 US$ 3.55 481,484 $ 353,777 482,425 $ 182,262 February 5, 2021 US$ 3.55 1,319,675 1,076,840 1,323,275 951,226 March 5, 2021 US$ 3.55 5,142,324 4,383,429 5,154,321 3,731,284 6,943,483 $ 5,814,046 6,960,021 $ 4,864,772
SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR WARRANTS	T SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR WARRANTS March 31, 2022 December 31, 2021 Risk free interest rate 2.17 % 0.23% 0.95 % Expected volatility 72.74% 126.97 % 70.95% 144.59 % Expected life 0.67 2.46 2 3 Expected dividend yield 0 % 0 %
SUMMARY OF CHANGES IN WARRANTS	SUMMARY OF CHANGES IN WARRANTS Number of Warrants Weighted Average Exercise Price Outstanding, December 31, 2020 2,416,864 $ 2.95 Exercised (1,939,534 ) 2.54 Forfeited (6,000 ) 2.50 Issued 7,943,489 5.10 Outstanding, December 31, 2021 8,414,819 $ 4.99 Exercised (16,538 ) 4.44 Outstanding, March 31, 2022 8,398,281 $ 4.99
SCHEDULE OF WARRANTS OUTSTANDING	As at March 31, 2022, the Company had the following warrants outstanding: SCHEDULE OF WARRANTS OUTSTANDING Date issued Expiry date Exercise price Number of warrants outstanding November 30, 2020 November 30, 2022 3.55 481,484 February 5, 2021 February 5, 2023 3.55 1,319,675 March 5, 2021 March 5, 2023 US$ 3.55 5,142,324 March 22, 2021 March 22, 2023 13.35 1,200,000 July 29, 2021 July 29, 2024 US$ 5.00 250,000 September 14, 2021 September 14, 2024 US$ 5.00 4,798 8,398,281

REVENUE (Tables)

REVENUE (Tables)	3 Months Ended
	Mar. 31, 2022
SCHEDULE OF PRODUCT AND SERVICE REVENUE	SCHEDULE OF PRODUCT AND SERVICE REVENUE For the period ended March 31, 2022 2021 Product sales $ 1,637,716 $ 1,129,307 Drone service 406,096 409,963 Services 750 466 Revenue $ 2,044,562 $ 1,539,736
SCHEDULE OF GEOGRAPHIC REVENUE	Geographic revenue segmentation is as follows: SCHEDULE OF GEOGRAPHIC REVENUE For the three months ended March 31, 2022 2021 For the three months ended March 31, 2022 2021 Canada $ 1,467,830 $ 769,380 United States 576,732 770,356 Revenue $ 2,044,562 $ 1,539,736
SCHEDULE OF OPERATING SEGMENTS	Non-current assets for each geographic segment are as follows: SCHEDULE OF OPERATING SEGMENTS As at March 31, 2022 Canada United States As at March 31, 2022 Canada United States Goodwill $ 2,166,564 $ 3,719,669 Property and equipment 293,179 - Intangible assets 208,139 336,285 Investments 257,817 - Notes receivable 786,055 1,143,432 Right of use assets 437,266 - Total assets $ 4,149,020 $ 5,199,386

OFFICE AND MISCELLANEOUS (Table

OFFICE AND MISCELLANEOUS (Tables)	3 Months Ended
	Mar. 31, 2022
SCHEDULE OF OFFICE AND MISCELLANEOUS EXPENSES	SCHEDULE OF OFFICE AND MISCELLANEOUS EXPENSES For the three months ended March 31, 2022 2021 Advertising, Marketing, and Investor Relations $ 1,159,773 $ 2,095,092 Compliance fees 47,380 115,734 Contract Work 214,848 34,077 Other 185,836 80,883 Office and Miscellaneous Expenses $ 1,607,837 $ 2,325,786

RELATED PARTY TRANSACTIONS (Tab

RELATED PARTY TRANSACTIONS (Tables)	3 Months Ended
	Mar. 31, 2022
SCHEDULE OF KEY MANAGEMENT TRANSACTIONS	Key management includes the Company’s directors and members of the executive management team. Compensation awarded to key management for the three months ended March 31, 2022 and 2021 included: SCHEDULE OF KEY MANAGEMENT TRANSACTIONS For the three months ended March 31, 2022 2021 Director fees $ 107,446 $ 86,691 Management fees paid to a company controlled by CEO and director 100,000 53,764 Management fees paid to a company controlled by the President and director 62,500 44,123 Management fees paid to a company controlled by a former director 82,993 45,000 Salaries 127,565 122,976 Share-based payments 322,083 680,097 Total $ 802,587 1,032,651

SCHEDULE OF RESULTS OF OPERATIO

SCHEDULE OF RESULTS OF OPERATIONS (Details)	3 Months Ended
	Mar. 31, 2022
Draganfly Innovations Inc. [member]
Reserve Quantities [Line Items]
Name of subsidiary	Draganfly Innovations Inc.
Country of incorporation of subsidiary	Canada
Proportion of ownership interest in subsidiary	100.00%
Draganfly Innovations USA, Inc. [member]
Reserve Quantities [Line Items]
Name of subsidiary	Draganfly Innovations USA, Inc.
Country of incorporation of subsidiary	US
Proportion of ownership interest in subsidiary	100.00%
Dronelogics Systems Inc. [member]
Reserve Quantities [Line Items]
Name of subsidiary	Dronelogics Systems Inc.
Country of incorporation of subsidiary	Canada
Proportion of ownership interest in subsidiary	100.00%

SCHEDULE OF ADJUSTMENTS TO COMP

SCHEDULE OF ADJUSTMENTS TO COMPARATIVE FINANCIAL INFORMATION (Details) - CAD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Dec. 31, 2020
IfrsStatementLineItems [Line Items]
Weighted average number of shares outstanding - basic & diluted	33,185,860	20,980,046
Basic and diluted earnings loss per share	$ (0.19)	$ (2.15)
Shareholders' equity	$ 29,373,050	$ (13,366,123)	$ 34,926,239	$ 3,848,205
Issued capital [member]
IfrsStatementLineItems [Line Items]
Basic and diluted earnings loss per share		$ (2.15)
Shareholders' equity	$ 81,159,345	$ 63,543,910	$ 81,038,365	$ 36,943,304
Equity Reserve [member]
IfrsStatementLineItems [Line Items]
Shareholders' equity		$ 4,123,720
Previously Reported [Member]
IfrsStatementLineItems [Line Items]
Weighted average number of shares outstanding - basic & diluted		21,070,046
Shareholders' equity		$ 381,485
Previously Reported [Member] | Issued capital [member]
IfrsStatementLineItems [Line Items]
Basic and diluted earnings loss per share		$ (2.15)
Shareholders' equity		$ 75,459,911
Previously Reported [Member] | Equity Reserve [member]
IfrsStatementLineItems [Line Items]
Shareholders' equity		$ 5,955,327
Revision of Prior Period, Adjustment [Member]
IfrsStatementLineItems [Line Items]
Weighted average number of shares outstanding - basic & diluted		(90,000)
Shareholders' equity		$ (13,747,308)
Revision of Prior Period, Adjustment [Member] | Issued capital [member]
IfrsStatementLineItems [Line Items]
Basic and diluted earnings loss per share
Shareholders' equity		$ (11,916,001)
Revision of Prior Period, Adjustment [Member] | Equity Reserve [member]
IfrsStatementLineItems [Line Items]
Shareholders' equity		$ (1,831,607)

SCHEDULE OF CONTINGENT CONSIDER

SCHEDULE OF CONTINGENT CONSIDERATION (Details) - CAD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Vital Acquisition
Contingent consideration, beginning balance	$ 694,230	$ 4,797,717
Change in fair value of contingent consideration	282,587	(4,103,487)
Contingent consideration, ending balance	$ 976,816	$ 694,230

SCHEDULE OF PURCHASE PRICE ALLO

SCHEDULE OF PURCHASE PRICE ALLOCATION FOR VITAL INTELLIGENCE (Details)	3 Months Ended
	Mar. 31, 2022CAD ($)$ / sharesshares
Vital Acquisition
Number of units of Draganfly Inc. | shares	578,248
Fair value of units | $ / shares	$ 14.43
Fair value of units of Draganfly Inc.	$ 8,342,966
Cash portion of purchase price	466,643
Total	8,809,609
Brand	23,000
Software	433,000
Identifiable intangible assets	456,000
Goodwill	8,353,609
Total consideration	$ 8,809,609

VITAL ACQUISITION (Details Narr

VITAL ACQUISITION (Details Narrative)	Aug. 19, 2021CAD ($)shares	Mar. 25, 2021CAD ($)$ / sharesshares	Mar. 31, 2022CAD ($)	Dec. 31, 2021shares
IfrsStatementLineItems [Line Items]
Shares held in escrow	900,000
Shares issued during period forfeited and cancelled	900,000
Derivative financial liabilities | $		$ 4,797,717
Increase (decrease) in credit derivative, fair value | $			$ 976,816
Vital Intelligence Inc [member]
IfrsStatementLineItems [Line Items]
Number of shares issued				1,200,000
Vital Intelligence Inc [member] | Brand [member]
IfrsStatementLineItems [Line Items]
Royalty Percentage		0.0025
Royalty discount percentage		0.144
Vital Intelligence Inc [member] | Software [member]
IfrsStatementLineItems [Line Items]
Royalty Percentage		0.050
Royalty discount percentage		0.144
Asset Purchase Agreement [member] | Vital Intelligence Inc [member]
IfrsStatementLineItems [Line Items]
Payment to acquire assets | $		$ 500,000
Number of shares issued		1,200,000
Explanation of nature and amount of significant transactions		the Company with each unit being comprised of one common share and one warrant (the “Acquisition”). Each warrant will entitle the holder to acquire one common share for a period of 24 ‎months following closing for $13.35 and the Company will be able ‎to accelerate the expiry date of the warrants after one year in the event the underlying common shares ‎have a value of at least 30% greater than the exercise price of the warrants. The units will be held in ‎escrow with 300,000 units being released at closing and the remainder to be released ‎upon the Company reaching certain revenue milestones received from the purchased assets.
Warrant exercise price per share | $ / shares		$ 13.35
Escrow deposit units		300,000
Description for number of shares issued		The units were issued on March 22, 2021
Asset Purchase Agreement [member] | Vital Intelligence Inc [member] | Maximum [Member]
IfrsStatementLineItems [Line Items]
Final payment | $	$ 250,000
Asset Purchase Agreement [member] | Vital Intelligence Inc [member] | Minimum [Member]
IfrsStatementLineItems [Line Items]
Final payment | $	$ 227,984
Escrow Agreement One [member]
IfrsStatementLineItems [Line Items]
Stock issued, shares	300,000
Escrow Agreement Two [member]
IfrsStatementLineItems [Line Items]
Stock issued, shares	300,000
Shares issued, amount | $	$ 2,000,000
Escrow Agreement Three [member]
IfrsStatementLineItems [Line Items]
Stock issued, shares	300,000
Shares issued, amount | $	$ 4,000,000
Escrow Agreement Four [member]
IfrsStatementLineItems [Line Items]
Stock issued, shares	300,000
Shares issued, amount | $	$ 6,000,000

SCHEDULE OF CASH AND CASH EQUIV

SCHEDULE OF CASH AND CASH EQUIVALENTS (Details) - CAD ($)	Mar. 31, 2022	Dec. 31, 2021
Cash held in banks	$ 19,231,149	$ 22,729,212
Guaranteed investment certificates	345,753	346,501
Cash and Cash Equivalents	$ 19,576,902	$ 23,075,713

SCHEDULE OF AMOUNTS RECEIVABLE

SCHEDULE OF AMOUNTS RECEIVABLE (Details) - CAD ($)	Mar. 31, 2022	Dec. 31, 2021
Schedule Of Amounts Receivable
Trade accounts receivable	$ 1,458,502	$ 951,314
Corporate taxes receivable	182,820	182,820
GST receivable	310,123	272,993
Trade and other receivables	$ 1,951,445	$ 1,407,127

SCHEDULE OF INVENTORIES (Detail

SCHEDULE OF INVENTORIES (Details) - CAD ($)	Mar. 31, 2022	Dec. 31, 2021
Finished goods	$ 2,997,812	$ 3,017,363
Parts	367,361	373,459
Inventories	$ 3,365,173	$ 3,390,822

SCHEDULE OF COST OF SALES (Deta

SCHEDULE OF COST OF SALES (Details) - CAD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Inventory	$ 1,161,511	$ 784,095
Consulting and services	64,833	162,393
Other	2,068	78,241
Cost of sales	$ 1,228,412	$ 1,024,729

INVENTORY (Details Narrative)

INVENTORY (Details Narrative) - CAD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Sale of inventory	$ 1,161,511	$ 784,095

DISCLOSURE OF NOTES RECEIVABLE

DISCLOSURE OF NOTES RECEIVABLE (Details) - CAD ($)		3 Months Ended
		Mar. 31, 2022	Dec. 31, 2021
IfrsStatementLineItems [Line Items]
Principal		$ 1,121,767
Interest		26,350
Accretion		10,110
Impairment recovery		771,260
Total		1,929,487
Notes receivables current		967,766	$ 190,170
Notes receivables non-current		$ 961,721	$ 964,006
Note One [member]
IfrsStatementLineItems [Line Items]
Start Date	[1]	Apr. 21, 2021
Maturity Date	[1]	Oct. 21, 2022
Interest Rate	[1]	0.00%
Principal	[1]	$ 178,223
Interest	[1]
Accretion	[1]	3,488
Impairment recovery	[1]
Total	[1]	181,711
Notes receivables current		181,711
Notes receivables non-current
Note Two [member]
IfrsStatementLineItems [Line Items]
Start Date	[1]	Sep. 22, 2021
Maturity Date	[1]	Sep. 22, 2024
Interest Rate	[1]	5.00%
Principal	[1]	$ 943,544
Interest	[1]	11,555
Accretion	[1]	6,622
Impairment recovery	[1]
Total	[1]	961,721
Notes receivables current
Notes receivables non-current		$ 961,721
Note Three [member]
IfrsStatementLineItems [Line Items]
Start Date		Nov. 17, 2021
Maturity Date		Apr. 26, 2022
Interest Rate		8.00%
Principal
Interest		14,795
Accretion
Impairment recovery		771,260
Total		786,055
Notes receivables current		786,055
Notes receivables non-current
[1]	These notes are denominated in US dollars and are converted to Canadian dollars at the reporting date.

NOTES RECEIVABLE (Details Narra

NOTES RECEIVABLE (Details Narrative) - CAD ($)		1 Months Ended	3 Months Ended	12 Months Ended
		Apr. 15, 2022	Mar. 31, 2022	Dec. 31, 2021
Upon execution [member]
IfrsStatementLineItems [Line Items]
Payment from notes receivable		$ 450,000	$ 450,000
Subsequent to period [member]
IfrsStatementLineItems [Line Items]
Payment from notes receivable		$ 450,000	$ 450,000
Note Two [member]
IfrsStatementLineItems [Line Items]
Note receivable interest rate	[1]		5.00%
Maturity Date	[1]		Sep. 22, 2024
Note Three [member]
IfrsStatementLineItems [Line Items]
Note receivable interest rate			8.00%
Maturity Date			Apr. 26, 2022
Loans written down
[1]	These notes are denominated in US dollars and are converted to Canadian dollars at the reporting date.

SCHEDULE OF PREPAID EXPENSES AN

SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details) - CAD ($)	Mar. 31, 2022	Dec. 31, 2021
Insurance	$ 1,464,830	$ 2,938,246
Prepaid director fees	107,778	107,763
Prepaid interest	2,699	6,969
Prepaid marketing services	1,173,062	1,638,179
Prepaid rent	10,255
Prepaid subscriptions	6,611	35,687
Deposits	587,317	768,033
Prepaid expenses and deposits	$ 3,352,552	$ 5,494,877

SCHEDULE OF INVESTMENTS (Detail

SCHEDULE OF INVESTMENTS (Details)	3 Months Ended
	Mar. 31, 2022CAD ($)
IfrsStatementLineItems [Line Items]
Balance at December 31, 2021	$ 291,066
Change in fair value	(33,249)
Balance at December 31, 2021	257,817
Public Company Shares [member]
IfrsStatementLineItems [Line Items]
Balance at December 31, 2021	128,571
Public Company Warrants [member]
IfrsStatementLineItems [Line Items]
Balance at December 31, 2021	4,286
Private Company Shares [member]
IfrsStatementLineItems [Line Items]
Balance at December 31, 2021	$ 124,960

SCHEDULE OF WEIGHTED AVERAGE AS

SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR FAIR VALUES WARRANTS (Details)	Mar. 10, 2021	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
IfrsStatementLineItems [Line Items]
Risk free interest rate		2.38%
Expected volatility		69.83%
Expected life		5 years	5 years
Expected dividend yield		0.00%	0.00%
Warrants [member]
IfrsStatementLineItems [Line Items]
Risk free interest rate	0.28%	2.17%
Expected volatility	150.88%	98.41%
Expected life	2 years	11 months 15 days
Expected dividend yield	0.00%	0.00%		0.00%

INVESTMENTS (Details Narrative)

INVESTMENTS (Details Narrative)	Oct. 27, 2021USD ($)shares	Mar. 10, 2021CAD ($)shares
Disclosure of detailed information about investment property [abstract]
Number of shares purchased	50,000	1,428,571
Number of shares purchased, value	$ 100,000	$ 500,000

SCHEDULE OF PROPERTY, PLANT AND

SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details) - CAD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
IfrsStatementLineItems [Line Items]
Property, plant and equipment, cost, beginning balance	$ 466,934	$ 257,974
Additions	23,198	212,579
Revaluation		(3,619)
Disposals	(89,107)
Property, plant and equipment, cost, ending balance	401,025	466,934
Accumulated depreciation Property, plant and equipment, beginning balance	169,891	104,104
Charge for the period	16,306	65,787
Disposals	(78,351)
Accumulated depreciation Property, plant and equipment, ending balance	107,846	169,891
Property, plant and equipment, net	293,179	297,043
Computer equipment [member]
IfrsStatementLineItems [Line Items]
Property, plant and equipment, cost, beginning balance	54,110	24,397
Additions	21,517	29,713
Revaluation
Disposals	(18,688)
Property, plant and equipment, cost, ending balance	56,939	54,110
Accumulated depreciation Property, plant and equipment, beginning balance	25,291	12,392
Charge for the period	8,614	12,899
Disposals	(15,920)
Accumulated depreciation Property, plant and equipment, ending balance	17,985	25,291
Property, plant and equipment, net	38,954	28,819
Furniture And Equipment [member]
IfrsStatementLineItems [Line Items]
Property, plant and equipment, cost, beginning balance	342,472	171,606
Additions	1,681	170,866
Revaluation
Disposals	(36,100)
Property, plant and equipment, cost, ending balance	308,053	342,472
Accumulated depreciation Property, plant and equipment, beginning balance	102,277	59,963
Charge for the period	6,838	42,314
Disposals	(33,342)
Accumulated depreciation Property, plant and equipment, ending balance	75,773	102,277
Property, plant and equipment, net	232,280	240,195
Leasehold improvements [member]
IfrsStatementLineItems [Line Items]
Property, plant and equipment, cost, beginning balance	4,352	4,352
Additions
Revaluation
Disposals	(4,352)
Property, plant and equipment, cost, ending balance		4,352
Accumulated depreciation Property, plant and equipment, beginning balance	4,352	3,220
Charge for the period		1,132
Disposals	(4,352)
Accumulated depreciation Property, plant and equipment, ending balance		4,352
Property, plant and equipment, net
Computer software [member]
IfrsStatementLineItems [Line Items]
Property, plant and equipment, cost, beginning balance	29,967	29,967
Additions
Revaluation
Disposals	(29,967)
Property, plant and equipment, cost, ending balance		29,967
Accumulated depreciation Property, plant and equipment, beginning balance	24,737	22,496
Charge for the period		2,241
Disposals	(24,737)
Accumulated depreciation Property, plant and equipment, ending balance		24,737
Property, plant and equipment, net		5,230
Vehicles [member]
IfrsStatementLineItems [Line Items]
Property, plant and equipment, cost, beginning balance	36,033	27,652
Additions		12,000
Revaluation		(3,619)
Disposals
Property, plant and equipment, cost, ending balance	36,033	36,033
Accumulated depreciation Property, plant and equipment, beginning balance	13,234	6,033
Charge for the period	854	7,201
Disposals
Accumulated depreciation Property, plant and equipment, ending balance	14,088	13,234
Property, plant and equipment, net	$ 21,945	$ 22,799

SCHEDULE OF INTANGIBLE ASSETS A

SCHEDULE OF INTANGIBLE ASSETS AND GOODWILL (Details) - CAD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
IfrsStatementLineItems [Line Items]
Intangible assets and goodwill, cost, beginning balance	$ 6,754,340	$ 2,524,494
Intangible assets acquired in the Transaction		8,809,609
Impairment of Goodwill		(4,579,763)
Foreign exchange translation	(60,722)
Intangible assets and goodwill, cost, ending balance	6,693,618	6,754,340
Accumulated amortization, beginning balance	220,030	84,064
Change for the period	44,540	135,966
Foreign exchange translation	(1,609)
Accumulated amortization, ending balance	262,961	220,030
Intangible assets and goodwill, net	6,430,657	6,534,310
Patent [member]
IfrsStatementLineItems [Line Items]
Intangible assets and goodwill, cost, beginning balance	41,931	41,931
Intangible assets acquired in the Transaction
Impairment of Goodwill
Foreign exchange translation
Intangible assets and goodwill, cost, ending balance	41,931	41,931
Accumulated amortization, beginning balance	41,931	41,931
Change for the period
Foreign exchange translation
Accumulated amortization, ending balance	41,931	41,931
Intangible assets and goodwill, net
Customer Relationship [member]
IfrsStatementLineItems [Line Items]
Intangible assets and goodwill, cost, beginning balance	197,000	197,000
Intangible assets acquired in the Transaction
Impairment of Goodwill
Foreign exchange translation
Intangible assets and goodwill, cost, ending balance	197,000	197,000
Accumulated amortization, beginning balance	60,414	26,267
Change for the period	6,289	34,147
Foreign exchange translation
Accumulated amortization, ending balance	67,243	60,414
Intangible assets and goodwill, net	129,757	136,586
Brand [member]
IfrsStatementLineItems [Line Items]
Intangible assets and goodwill, cost, beginning balance	23,000
Intangible assets acquired in the Transaction		23,000
Impairment of Goodwill
Foreign exchange translation	(330)
Intangible assets and goodwill, cost, ending balance	22,670	23,000
Accumulated amortization, beginning balance	3,450
Change for the period	1,149	3,450
Foreign exchange translation	(65)
Accumulated amortization, ending balance	4,534	3,450
Intangible assets and goodwill, net	18,136	19,550
Software [member]
IfrsStatementLineItems [Line Items]
Intangible assets and goodwill, cost, beginning balance	552,000	119,000
Intangible assets acquired in the Transaction		433,000
Impairment of Goodwill
Foreign exchange translation	(6,216)
Intangible assets and goodwill, cost, ending balance	545,784	552,000
Accumulated amortization, beginning balance	114,235	15,866
Change for the period	36,562	98,369
Foreign exchange translation	(1,544)
Accumulated amortization, ending balance	149,253	114,235
Intangible assets and goodwill, net	396,531	437,765
Goodwill [member]
IfrsStatementLineItems [Line Items]
Intangible assets and goodwill, cost, beginning balance	5,940,409	2,166,563
Intangible assets acquired in the Transaction		8,353,609
Impairment of Goodwill		(4,579,763)
Foreign exchange translation	(54,176)
Intangible assets and goodwill, cost, ending balance	5,886,233	5,940,409
Accumulated amortization, beginning balance
Change for the period
Foreign exchange translation
Accumulated amortization, ending balance
Intangible assets and goodwill, net	$ 5,886,233	$ 5,940,409

INTANGIBLE ASSETS AND GOODWIL_2

INTANGIBLE ASSETS AND GOODWILL (Details Narrative) - CAD ($)	12 Months Ended
	Dec. 31, 2021	Mar. 31, 2022	Mar. 25, 2021	Apr. 30, 2020
IfrsStatementLineItems [Line Items]
Goodwill	$ 5,940,409	$ 5,886,233
Impairment of goodwill	$ 4,579,763
Assumption discount rates		10.00%
Vital [member]
IfrsStatementLineItems [Line Items]
Percentage of weighted average revenue margin	42.00%
Percentage of weighted average cost of capital	24.00%
Reduction in value		$ 570,133
Dronelogics [member]
IfrsStatementLineItems [Line Items]
Percentage of weighted average revenue margin	14.00%
Percentage of weighted average cost of capital	17.00%
Reduction in value		$ 597,100
Vital and Dronelogics [member]
IfrsStatementLineItems [Line Items]
Percentage of cash flow projection	2.00%
Brand [member]
IfrsStatementLineItems [Line Items]
Impairment of goodwill
Brand [member] | Vital [member]
IfrsStatementLineItems [Line Items]
Intangible assets			$ 23,000
Computer software [member] | Vital [member]
IfrsStatementLineItems [Line Items]
Intangible assets			433,000
Goodwill [member]
IfrsStatementLineItems [Line Items]
Impairment of goodwill	$ 4,579,763
Goodwill [member] | Vital [member]
IfrsStatementLineItems [Line Items]
Goodwill			$ 8,353,609
Goodwill [member] | Dronelogics [member]
IfrsStatementLineItems [Line Items]
Percentage of acquired				100.00%
Goodwill				$ 2,166,563

SCHEDULE OF RIGHT OF USE ASSETS

SCHEDULE OF RIGHT OF USE ASSETS (Details) - CAD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Right of use assets, cost, beginning	$ 683,117	$ 242,967
Additions		447,242
Lease removal		(7,092)
Right of use assets, cost, ending	683,117	683,117
Accumulated amortization, beginning	215,011	98,548
Charge for the period	30,840	109,311
Historical correction		7,152
Accumulated amortization, ending	245,851	215,011
Right of use assets, net	$ 437,266	$ 468,106

SCHEDULE OF OPERATING LEASE LIA

SCHEDULE OF OPERATING LEASE LIABILITIES (Details) - CAD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Disclosure of maturity analysis of operating lease payments [abstract]
Lease liabilities, beginning of period	$ 489,123	$ 158,124
Additions		440,675
Interest expense	10,927	26,964
Lease payments	(36,583)	(128,995)
Lease removal		(7,645)
Lease liabilities	463,467	489,123
Current lease liabilities	115,269	110,481
Non-current lease liabilities	$ 348,198	$ 378,642

SCHEDULE OF OPERATING MATURITY

SCHEDULE OF OPERATING MATURITY ANALYSIS (Details) - CAD ($)	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
IfrsStatementLineItems [Line Items]
Maturity analysis	$ 550,963
Amount representing implicit interest	(87,496)
Lease liability	463,467	$ 489,123	$ 158,124
Not later than one year [member]
IfrsStatementLineItems [Line Items]
Maturity analysis	150,276
Later than one year and not later than three years [member]
IfrsStatementLineItems [Line Items]
Maturity analysis	238,347
Later than four years and not later than five years [member]
IfrsStatementLineItems [Line Items]
Maturity analysis	162,340
Later than five years [member]
IfrsStatementLineItems [Line Items]
Maturity analysis

LEASE LIABILITY (Details Narrat

LEASE LIABILITY (Details Narrative)	3 Months Ended
	Mar. 31, 2022
Disclosure of maturity analysis of operating lease payments [abstract]
Depreciation Lease Liability	The Company leases certain assets under lease agreements. The lease liabilities consist of leases of facilities and vehicles with terms ranging from one to five years. The leases are calculated using incremental borrowing rates ranging from 7.5% to 10.5%

SCHEDULE OF TRADE PAYABLES AND

SCHEDULE OF TRADE PAYABLES AND ACCRUED LIABILITIES (Details) - CAD ($)	Mar. 31, 2022	Dec. 31, 2021
Trade accounts payable	$ 415,814	$ 362,890
Accrued liabilities	219,465	402,540
Government grant payable	33,709	33,709
Trade payables and accrued liabilities	$ 668,988	$ 799,139

SCHEDULE OF LOANS PAYABLE (Deta

SCHEDULE OF LOANS PAYABLE (Details) - CAD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Opening balance	$ 93,317	$ 97,916
Issuance of loans payable		60,000
Fair value adjustment		(24,576)
Repayment of loans payable	(1,687)	(44,428)
Accretion expense	1,276	4,405
Ending balance	$ 92,906	$ 93,317

SCHEDULE OF LOANS (Details)

SCHEDULE OF LOANS (Details) - CAD ($)	3 Months Ended
	Mar. 31, 2022	Dec. 31, 2021	Apr. 23, 2021	May 19, 2020
IfrsStatementLineItems [Line Items]
Rate				25.00%
Total Carrying Value	$ 92,906	$ 93,317
CEBA [member]
IfrsStatementLineItems [Line Items]
Start Date	May 19, 2020
Maturity Date	Dec. 31, 2022
Rate	0.00%		5.00%	5.00%
Total Carrying Value	$ 38,021	37,384
CEBA [member]
IfrsStatementLineItems [Line Items]
Start Date	Apr. 23, 2021
Maturity Date	Dec. 31, 2022
Rate	0.00%
Total Carrying Value	$ 38,021	37,383
Vehicle Loan [member]
IfrsStatementLineItems [Line Items]
Start Date	Aug. 30, 2019
Maturity Date	Sep. 11, 2024
Rate	6.99%
Total Carrying Value	$ 16,864	$ 18,550

LOANS PAYABLE (Details Narrativ

LOANS PAYABLE (Details Narrative) - CAD ($)	Apr. 23, 2021	Dec. 04, 2020	May 19, 2020	Mar. 31, 2022
IfrsStatementLineItems [Line Items]
Interest rate			25.00%
CEBA [member]
IfrsStatementLineItems [Line Items]
Loans received			$ 40,000
Interest rate	5.00%		5.00%	0.00%
Loans forgivable amount	$ 20,000		$ 10,000
Proceeds from loan		$ 20,000
Loan forgiveness		$ 10,000
Unsecured loan received	$ 60,000

SCHEDULE OF STOCK OPTIONS OUTST

SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE (Details)	3 Months Ended	12 Months Ended
	Mar. 31, 2022shares$ / shares	Dec. 31, 2021shares	Dec. 31, 2020shares
IfrsStatementLineItems [Line Items]
Remaining Contractual Life (years)	11 months 15 days	1 year 2 months 12 days
Number of Options Outstanding	1,023,491	1,035,991	1,193,659
Number of Options Exercisable	710,497
Exercise Price One [member]
IfrsStatementLineItems [Line Items]
Grant Date	Oct. 30, 2019
Expiry Date	Oct. 30, 2029
Exercise Price | $ / shares	$ 2.50
Remaining Contractual Life (years)	7 years 7 months 2 days
Number of Options Outstanding	296,665
Number of Options Exercisable	296,665
Exercise Price Two [member]
IfrsStatementLineItems [Line Items]
Grant Date	Nov. 19, 2019
Expiry Date	Nov. 19, 2029
Exercise Price | $ / shares	$ 2.50
Remaining Contractual Life (years)	7 years 7 months 20 days
Number of Options Outstanding	50,000
Number of Options Exercisable	50,000
Exercise Price Three [member]
IfrsStatementLineItems [Line Items]
Grant Date	Apr. 30, 2020
Expiry Date	Apr. 30, 2030
Exercise Price | $ / shares	$ 2.50
Remaining Contractual Life (years)	8 years 1 month 2 days
Number of Options Outstanding	87,000
Number of Options Exercisable	78,666
Exercise Price Four [member]
IfrsStatementLineItems [Line Items]
Grant Date	Apr. 30, 2020
Expiry Date	Apr. 30, 2030
Exercise Price | $ / shares	$ 3.85
Remaining Contractual Life (years)	8 years 1 month 2 days
Number of Options Outstanding	110,000
Number of Options Exercisable	70,000
Exercise Price Five [member]
IfrsStatementLineItems [Line Items]
Grant Date	Jul. 3, 2020
Expiry Date	Jul. 3, 2025
Exercise Price | $ / shares	$ 3.20
Remaining Contractual Life (years)	3 years 3 months 3 days
Number of Options Outstanding	200,000
Number of Options Exercisable	166,666
Exercise Price Six [member]
IfrsStatementLineItems [Line Items]
Grant Date	Nov. 24, 2020
Expiry Date	Nov. 24, 2030
Exercise Price | $ / shares	$ 2.50
Remaining Contractual Life (years)	8 years 7 months 28 days
Number of Options Outstanding	32,000
Number of Options Exercisable	21,000
Exercise Price Seven [member]
IfrsStatementLineItems [Line Items]
Grant Date	Feb. 2, 2021
Expiry Date	Feb. 2, 2031
Exercise Price | $ / shares	$ 13.20
Remaining Contractual Life (years)	8 years 10 months 6 days
Number of Options Outstanding	30,000
Number of Options Exercisable	20,000
Exercise Price Eight [member]
IfrsStatementLineItems [Line Items]
Grant Date	Mar. 8, 2021
Expiry Date	Mar. 8, 2026
Exercise Price | $ / shares	$ 13.90
Remaining Contractual Life (years)	3 years 11 months 8 days
Number of Options Outstanding	10,000
Number of Options Exercisable	7,500
Exercise Price Nine [member]
IfrsStatementLineItems [Line Items]
Grant Date	Apr. 27, 2021
Expiry Date	Apr. 27, 2031
Exercise Price | $ / shares	$ 10.15
Remaining Contractual Life (years)	8 years 11 months 23 days
Number of Options Outstanding	182,000
Number of Options Exercisable
Exercise Price Ten [member]
IfrsStatementLineItems [Line Items]
Grant Date	Sep. 9, 2021
Expiry Date	Sep. 9, 2026
Exercise Price | $ / shares	$ 4.84
Remaining Contractual Life (years)	4 years 5 months 8 days
Number of Options Outstanding	25,826
Number of Options Exercisable

SUMMARY OF CHANGES IN STOCK OPT

SUMMARY OF CHANGES IN STOCK OPTIONS (Details)	3 Months Ended	12 Months Ended
	Mar. 31, 2022shares$ / shares	Dec. 31, 2021shares$ / shares
Number of options outstanding, Beginning Balance | shares	1,035,991	1,193,659
Weighted average exercise price, Beginning Balance | $ / shares	$ 4.60	$ 2.75
Number of options outstanding, forfeited | shares		(405,494)
Weighted average exercise price, forfeited | $ / shares		$ 2.50
Number of options outstanding, Granted | shares	0	247,826
Weighted average exercise price, Granted | $ / shares		$ 10.12
Number of options outstanding, Exercised | shares	(12,500)
Weighted average exercise price, Exercised | $ / shares	$ 2.50
Number of options outstanding, Ending Balance | shares	1,023,491	1,035,991
Weighted average exercise price, Ending Balance | $ / shares	$ 3.22	$ 4.60

SCHEDULE OF WEIGHTED AVERAGE _2

SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS (Details) - $ / shares	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
IfrsStatementLineItems [Line Items]
Risk free interest rate	2.38%
Expected volatility	69.83%
Expected life	5 years	5 years
Expected dividend yield	0.00%	0.00%
Bottom of range [member]
IfrsStatementLineItems [Line Items]
Risk free interest rate		0.69%
Expected volatility		111.87%
Exercise price	$ 13.90	$ 13.20
Top of range [member]
IfrsStatementLineItems [Line Items]
Risk free interest rate		1.40%
Expected volatility		113.16%
Exercise price		$ 13.90

SUMMARY OF CHANGES IN RESTRICTE

SUMMARY OF CHANGES IN RESTRICTED STOCK UNITS (Details) - shares	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
IfrsStatementLineItems [Line Items]
Number of RSUs outstanding, Beginning of the period	6,960,021
Number of RSUs outstanding, Ending of the period	6,943,483	6,960,021
Restricted Stock Units Rsu [member]
IfrsStatementLineItems [Line Items]
Number of RSUs outstanding, Beginning of the period	514,832	614,666
Vested		(448,660)
Issued		348,826
Number of RSUs outstanding, Ending of the period	514,832	514,832

SCHEDULE OF WARRANT DERIVATIVE

SCHEDULE OF WARRANT DERIVATIVE LIABILITY (Details)	3 Months Ended		12 Months Ended
	Mar. 31, 2022USD ($)	Mar. 31, 2022CAD ($)	Dec. 31, 2021USD ($)
IfrsStatementLineItems [Line Items]
Contingent consideration		$ 8,809,609
Warrants [member]
IfrsStatementLineItems [Line Items]
Beginning of the period	$ 4,865,772		$ 748,634
Warrants issuance			8,261,511
Exercised	(74,227)		(98,048)
Change in fair value of warrants outstanding	1,022,501		(4,046,325)
End of the period	5,814,046		$ 4,865,772
Warrants		5,814,046
Contingent consideration		$ 976,816
Derivative liability	$ 6,790,862

SCHEDULE OF WARRANTS AND FAIR V

SCHEDULE OF WARRANTS AND FAIR VALUE OUTSTANDING (Details)	3 Months Ended
	Mar. 31, 2022USD ($)shares$ / shares	Dec. 31, 2021USD ($)shares
IfrsStatementLineItems [Line Items]
Number of Warrants Outstanding | shares	6,943,483	6,960,021
Fair Value of warrants | $	$ 5,814,046	$ 4,864,772
Range 1 [member]
IfrsStatementLineItems [Line Items]
Issue Date	Nov. 30, 2020
Exercise price | $ / shares	$ 3.55
Number of Warrants Outstanding | shares	481,484	482,425
Fair Value of warrants | $	$ 353,777	$ 182,262
Range 2 [member]
IfrsStatementLineItems [Line Items]
Issue Date	Feb. 5, 2021
Exercise price | $ / shares	$ 3.55
Number of Warrants Outstanding | shares	1,319,675	1,323,275
Fair Value of warrants | $	$ 1,076,840	$ 951,226
Range 3 [member]
IfrsStatementLineItems [Line Items]
Issue Date	Mar. 5, 2021
Exercise price | $ / shares	$ 3.55
Number of Warrants Outstanding | shares	5,142,324	5,154,321
Fair Value of warrants | $	$ 4,383,429	$ 3,731,284

SCHEDULE OF WEIGHTED AVERAGE _3

SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR WARRANTS (Details)	Mar. 10, 2021	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
IfrsStatementLineItems [Line Items]
Risk free interest rate		2.38%
Expected volatility		69.83%
Expected life		5 years	5 years
Expected dividend yield		0.00%	0.00%
Bottom of range [member]
IfrsStatementLineItems [Line Items]
Risk free interest rate			0.69%
Expected volatility			111.87%
Top of range [member]
IfrsStatementLineItems [Line Items]
Risk free interest rate			1.40%
Expected volatility			113.16%
Warrants [member]
IfrsStatementLineItems [Line Items]
Risk free interest rate	0.28%	2.17%
Expected volatility	150.88%	98.41%
Expected life	2 years	11 months 15 days
Expected dividend yield	0.00%	0.00%		0.00%
Warrants [member] | Bottom of range [member]
IfrsStatementLineItems [Line Items]
Risk free interest rate				0.23%
Expected volatility		72.74%		70.95%
Expected life		8 months 1 day		2 years
Warrants [member] | Top of range [member]
IfrsStatementLineItems [Line Items]
Risk free interest rate				0.95%
Expected volatility		126.97%		144.59%
Expected life		2 years 5 months 15 days		3 years

SUMMARY OF CHANGES IN WARRANTS

SUMMARY OF CHANGES IN WARRANTS (Details)	3 Months Ended	12 Months Ended
	Mar. 31, 2022shares$ / shares	Dec. 31, 2021shares$ / shares
IfrsStatementLineItems [Line Items]
Number of RSUs outstanding, Beginning of the period | shares	6,960,021
Number of RSUs outstanding, Ending of the period | shares	6,943,483	6,960,021
Warrants [member]
IfrsStatementLineItems [Line Items]
Number of RSUs outstanding, Beginning of the period	8,414,819	2,416,864
Weighted Average Exercise Price, Outstanding, Beginning Balance	$ 4.99	$ 2.95
Warrants, Excercised	(16,538)	(1,939,534)
Weighted Average Exercise Price, Issued	$ 4.44	$ 2.54
Warrants, Forfeited		(6,000)
Weighted Average Exercise Price, Forfeited		$ 2.50
Warrants, Issued		7,943,489
Weighted Average Exercise Price, Issued		$ 5.10
Number of RSUs outstanding, Ending of the period	8,398,281	8,414,819
Weighted Average Exercise Price, Outstanding, Ending Balance	$ 4.99	$ 4.99

SCHEDULE OF WARRANTS OUTSTANDIN

SCHEDULE OF WARRANTS OUTSTANDING (Details)	3 Months Ended
	Mar. 31, 2022$ / sharesshares	Mar. 31, 2022$ / sharesshares
Warrant One [member]
IfrsStatementLineItems [Line Items]
Date issued	Nov. 30, 2020
Expiry date	Nov. 30, 2022
Exercise price | $ / shares	$ 3.55
Number of warrants outstanding	481,484	481,484
Warrant Two [member]
IfrsStatementLineItems [Line Items]
Date issued	Feb. 5, 2021
Expiry date	Feb. 5, 2023
Exercise price | $ / shares	$ 3.55
Number of warrants outstanding	1,319,675	1,319,675
Warrant Three [member]
IfrsStatementLineItems [Line Items]
Date issued	Mar. 5, 2021
Expiry date	Mar. 5, 2023
Exercise price | $ / shares	$ 3.55
Number of warrants outstanding	5,142,324	5,142,324
Warrant Four [member]
IfrsStatementLineItems [Line Items]
Date issued	Mar. 22, 2021
Expiry date	Mar. 22, 2023
Exercise price | $ / shares		$ 13.35
Number of warrants outstanding	1,200,000	1,200,000
Warrant Five [member]
IfrsStatementLineItems [Line Items]
Date issued	Jul. 29, 2021
Expiry date	Jul. 29, 2024
Exercise price | $ / shares	$ 5
Number of warrants outstanding	250,000	250,000
Warrant Six [member]
IfrsStatementLineItems [Line Items]
Date issued	Sep. 14, 2021
Expiry date	Sep. 14, 2024
Exercise price | $ / shares	$ 5
Number of warrants outstanding	4,798	4,798
Warrants [member]
IfrsStatementLineItems [Line Items]
Number of warrants outstanding	8,398,281	8,398,281

SHARE CAPITAL (Details Narrativ

SHARE CAPITAL (Details Narrative) - CAD ($)	Mar. 22, 2021	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2021
IfrsStatementLineItems [Line Items]
Number of stock units issued for regulation financing					6,488,691
Stock units issued during period value regulation financing					$ 18,815,485
Share capital issuance, description					Each unit is comprised of one common share and one share purchase warrant. These warrants had a fair value of $0.57 USD allocated to them, have an exercise price of $3.55 USD per warrant, each convert to one common share, and have a life of two years
Warrant derivative liability					$ 8,261,511
Number of stock issued for private placement					5,095,966
Value of stock issued for private placement					$ 25,538,213
Number of share options granted in share-based payment arrangement		0			247,826
Weighted average exercise price of share options granted in share-based payment arrangement					$ 10.12
Adjustments for share-based payments		$ 643,325	$ 1,049,866
Weighted average remaining contractual life of outstanding share options		11 months 15 days			1 year 2 months 12 days
Warrants issued	1,200,000
Warrants held in escrow	900,000
Stock Options [member]
IfrsStatementLineItems [Line Items]
Adjustments for share-based payments		$ 297,566	$ 516,351
Restricted Stock Units [member]
IfrsStatementLineItems [Line Items]
Number of accelerated vesting shares					323,661
Number of shares vested					124,999
Number of shares granted post consolidation					348,826
Expense from share-based payment transactions with employees		$ 345,759		$ 533,515
Employee [member]
IfrsStatementLineItems [Line Items]
Number of share options granted in share-based payment arrangement					30,000
Weighted average exercise price of share options granted in share-based payment arrangement					$ 13.20
Contractual life of exercisable share options					10 years
Consultant [member]
IfrsStatementLineItems [Line Items]
Number of share options granted in share-based payment arrangement					10,000
Weighted average exercise price of share options granted in share-based payment arrangement					$ 13.90
Contractual life of exercisable share options					5 years
Employees and Consultant [member]
IfrsStatementLineItems [Line Items]
Number of share options granted in share-based payment arrangement					182,000
Weighted average exercise price of share options granted in share-based payment arrangement					$ 10.15
Contractual life of exercisable share options					10 years
Employee One [member]
IfrsStatementLineItems [Line Items]
Number of share options granted in share-based payment arrangement					25,826
Weighted average exercise price of share options granted in share-based payment arrangement					$ 4.84
Contractual life of exercisable share options					5 years
Vital Intelligence Inc [member]
IfrsStatementLineItems [Line Items]
Share capital issuance, description					Each unit is comprised of one common share and one warrant. These warrants have an exercise price of $13.35 per warrant, each convert to one common share, and have a life of two years.
Number of stock units issued for acquisition					1,200,000
Common Stock 1 [member]
IfrsStatementLineItems [Line Items]
Number of stock issued for exercise of warrants		16,538			1,580,525
Value of stock issued for exercise of warrants		$ 74,227			$ 3,951,312
Number of stock issued for exercise of options		12,500			392,999
Value of stock issued for exercise of options		$ 26,875			$ 987,248
Number of stock issued for restricted share units					149,999
Number of shares issued					15,000
Common Stock 2 [member]
IfrsStatementLineItems [Line Items]
Number of stock issued for exercise of warrants					359,009
Value of stock issued for exercise of warrants					$ 978,478
Number of stock issued for exercise of options					12,500
Value of stock issued for exercise of options					$ 26,875
Number of stock issued for restricted share units					298,661
Number of shares issued					356,901

SCHEDULE OF PRODUCT AND SERVICE

SCHEDULE OF PRODUCT AND SERVICE REVENUE (Details) - CAD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
IfrsStatementLineItems [Line Items]
Revenue	$ 2,044,562	$ 1,539,736
Product Sales [member]
IfrsStatementLineItems [Line Items]
Revenue	1,637,716	1,129,307
Drone Service [member]
IfrsStatementLineItems [Line Items]
Revenue	406,096	409,963
Services [member]
IfrsStatementLineItems [Line Items]
Revenue	$ 750	$ 466

SCHEDULE OF GEOGRAPHIC REVENUE

SCHEDULE OF GEOGRAPHIC REVENUE (Details) - CAD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Reserve Quantities [Line Items]
Revenue	$ 2,044,562	$ 1,539,736
CA Country [member]
Reserve Quantities [Line Items]
Revenue	1,467,830	769,380
US Country [member]
Reserve Quantities [Line Items]
Revenue	$ 576,732	$ 770,356

SCHEDULE OF OPERATING SEGMENTS

SCHEDULE OF OPERATING SEGMENTS (Details) - CAD ($)	Mar. 31, 2022	Dec. 31, 2021
IfrsStatementLineItems [Line Items]
Goodwill	$ 5,886,233	$ 5,940,409
Property and equipment	293,179	297,043
Intangible assets	544,424	593,901
Investments	257,817	291,066
Right of use assets	437,266	468,106
TOTAL ASSETS	37,594,478	$ 42,113,240
CA Country [member]
IfrsStatementLineItems [Line Items]
Goodwill	2,166,564
Property and equipment	293,179
Intangible assets	208,139
Investments	257,817
Notes receivable	786,055
Right of use assets	437,266
TOTAL ASSETS	4,149,020
US Country [member]
IfrsStatementLineItems [Line Items]
Goodwill	3,719,669
Property and equipment
Intangible assets	336,285
Investments
Notes receivable	1,143,432
Right of use assets
TOTAL ASSETS	$ 5,199,386

SCHEDULE OF OFFICE AND MISCELLA

SCHEDULE OF OFFICE AND MISCELLANEOUS EXPENSES (Details) - CAD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Advertising, Marketing, and Investor Relations	$ 1,159,773	$ 2,095,092
Compliance fees	47,380	115,734
Contract Work	214,848	34,077
Other	185,836	80,883
Office and Miscellaneous Expenses	$ 1,607,837	$ 2,325,786

SCHEDULE OF KEY MANAGEMENT TRAN

SCHEDULE OF KEY MANAGEMENT TRANSACTIONS (Details) - CAD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
IfrsStatementLineItems [Line Items]
Director fees	$ 107,446	$ 86,691
Management fees paid to a company controlled by a former director	873,640	868,479
Salaries	127,565	122,976
Share-based payments	322,083	680,097
Total	802,587	1,032,651
CEO and Director [member]
IfrsStatementLineItems [Line Items]
Management fees paid to a company controlled by a former director	100,000	53,764
President And Director [member]
IfrsStatementLineItems [Line Items]
Management fees paid to a company controlled by a former director	62,500	44,123
Former Owner [member]
IfrsStatementLineItems [Line Items]
Management fees paid to a company controlled by a former director	$ 82,993	$ 45,000

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative) - CAD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
IfrsStatementLineItems [Line Items]
Professional fees	$ 873,640	$ 868,479
Amounts payable, related party transactions
Business Service Agreement [member] | Business Instincts Group [member]
IfrsStatementLineItems [Line Items]
Professional fees	125,732	43,500
Amounts payable, related party transactions
Consultant Agreement [member] | Alberta Ltd [member]
IfrsStatementLineItems [Line Items]
Professional fees	100,000	53,764
Amounts payable, related party transactions
Executive Agreement [member] | Scott Larson [member]
IfrsStatementLineItems [Line Items]
Professional fees	62,500	$ 44,123
Amounts payable, related party transactions

SUPPLEMENTAL CASH FLOW DISCLO_2

SUPPLEMENTAL CASH FLOW DISCLOSURES (Details Narrative)	Dec. 31, 2021CAD ($)$ / sharesshares
Vital Intelligence Inc [member]
IfrsStatementLineItems [Line Items]
Number of shares issued	1,200,000
Warrant exercise price | $ / shares	$ 13.35
Common Shares [member]
IfrsStatementLineItems [Line Items]
Number of shares issued	15,000
Common Shares One [member]
IfrsStatementLineItems [Line Items]
Number of shares issued	356,901
Fair value of investments other comprehensive loss | $	$ 332,640

SUBSEQUENT EVENT (Details Narra

SUBSEQUENT EVENT (Details Narrative) - CAD ($)	1 Months Ended	3 Months Ended
	Apr. 15, 2022	Mar. 31, 2022	Mar. 31, 2021
IfrsStatementLineItems [Line Items]
Impairment of notes	$ 771,260	$ (771,260)
Upon execution [member]
IfrsStatementLineItems [Line Items]
Payment from notes receivable	450,000	450,000
Subsequent to period [member]
IfrsStatementLineItems [Line Items]
Payment from notes receivable	$ 450,000	$ 450,000